LOS ANGELES, Dec. 31 /PRNewswire/ -- The US largest AIDS organization today awarded its 2002 Heart of Stone to British pharmaceutical giant GlaxoSmithKline for putting profit above human decency while 8,500 die every day of AIDS. AHF -- which provides medical care to uninsured AIDS patients from California to
CHICAGO, Dec. 28 /PRNewswire/ -- John D. Moore, a 32-year old therapist and professor of health sciences at American Public University announced today that Liberation Publications has identified him as a 2002 Visionary for his work in the social services field as it relates to HIV/AIDS. Moore is the author of a newly r
-- AB 2168 (Gallegos, D, Los Angeles, 2000) Requires Standing Referrals, State, Community & Medical Groups Worked Together to Craft Definition of Specialist LOS ANGELES, Dec. 24 /PRNewswire/ -- Groundbreaking legislation ordering California HMOs to provide standing referrals to AIDS specialists for patients infecte
-- Celebrity-hosted 10-Part Series of Specials to Begin Airing On SHOWTIME January 19, 2003 -- Danny Glover to Host Premiere Episode on HIV/AIDS Epidemic: Angelina Jolie, Jeff Bridges, Laurence Fishburne & Michael Douglas Serve As Episode Hosts -- Nicole Silver and Orly Wiseman to Executive Produce Series NEW YORK,
INDIANAPOLIS, Dec. 23 /PRNewswire/ -- Following recent news of the U.S. Food and Drug Administration s ( FDA ) clearance of Roche Diagnostics COBAS AmpliScreen System for the blood banking industry, Roche is now pleased to announce FDA approval of the first two tests which are designed for use with this System -- the C
AIDS Healthcare Foundation Praises Physician/Senator s Medical Relief Work in Africa, Recognizes Frist s Leadership Sponsoring First US Global AIDS Funding Legislation LOS ANGELES, Dec. 21 /PRNewswire/ -- AIDS Healthcare Foundation, (AHF) the nation s largest AIDS organization which operates free AIDS clinics in the
PRINCETON, N.J., Dec. 20 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration ( FDA ) for atazanavir, an investigational protease inhibitor under development for the treatment of HIV/AIDS in combination
CAMBRIDGE, Mass., Dec. 20 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that GlaxoSmithKline (GSK) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration ( FDA ) for marketing approval of GW433908 (also known as 908 or VX-175), an investigation
Nelson Mandela to Host Extraordinary Event: People s Concert to Take Place Simultaneously at South Africa s Green Point Stadium in Conjunction With Concert at Robben Island NEW YORK, Dec. 19 /PRNewswire/ -- Some of the world s most celebrated recording artists have come together to answer Nelson Mandela s SOS to eradic
COLUMBIA, S.C., Dec. 19 /PRNewswire/ -- It s Christmas time at the State Capital in Columbia, but several South Carolina patient groups are not in a holiday mood. A new state Medicaid drug plan -- being considered by outgoing Governor Hodges -- has South Carolina patient advocates very concerned. The prescription drug
LOS ANGELES, Dec. 19 /PRNewswire/ -- The largest AIDS organization in the United States today announced that it has filed a motion for a Preliminary Injunction against GlaxoSmithKline (GSK) and related companies in its federal anti-trust complaint against the British-owned pharmaceutical giant. AIDS Healthcare Foundat
MUMBAI, India , Dec. 19 /PRNewswire/ -- In the first-ever event of its kind, leading Indian celebrities will gather in Mumbai, India on December 20 to raise awareness of India s HIV/AIDS epidemic, and to lend their support to efforts to reduce mother-to-child transmission of the virus. The event, A Time for Heroes Ind
CARLSBAD, Calif., Dec. 19 /PRNewswire-FirstCall/ -- The Immune Response Corporation (Nasdaq: IMNR) announced today it has been granted Republic of South Africa Patent Number 2001/8559 entitled HIV Immunogenic Compositions and Methods for its latest vaccine development utilizing a novel formulation of REMUNE(R) in conce
NUTLEY, N.J., and DURHAM, N.C., Dec. 18 /PRNewswire-FirstCall/ -- As part of the stated commitment to keep interested parties informed on the development of their investigational HIV drug, Roche and Trimeris now have enough data from the first three months of experience of the commercial manufacturing process of FUZEON
AMSTERDAM, Netherlands , Dec. 18 /PRNewswire/ -- Primagen today presented new pre-clinical data on its proprietary Mitox tests at the HIV-1 DART conference in Florida, where frontiers in drug development for antiretroviral therapies are discussed among the worlds best drug developers and scientists. Primagen s Mito
MONTREAL, Dec. 18 /PRNewswire/ - Pharmacor Inc. has been issued U.S. patent application no. 09/963,329 relating to its antiretroviral program. The small-molecule compounds described in the patent, entitled Aromatic derivatives with HIV integrase inhibitory properties, are novel anti-HIV lead molecules that target a nov
- Danny Glover to Host Premiere Episode on HIV/AIDS Epidemic - Angelina Jolie, Jeff Bridges, Laurence Fishburne & Michael Douglas Serve As Episode Hosts Nicole Silver and Orly Wiseman to Executive Produce Series NEW YORK, Dec. 17 /PRNewswire/ -- Showtime Networks has reached an agreement with RCN Entertainment to p
PHILADELPHIA, Dec. 17 /PRNewswire-FirstCall/ -- Hemispherx Biopharma Inc. (Amex: HEB) today presented new data from a Phase IIB clinical trial of its experimental compound, RNA-based Ampligen(R), on Structured Treatment Interruption (STI) in HIV. Gary Blick, M.D. and Hemispherx s Clinical Director, David Strayer, M.D.,
-- Partnership Between Nation s Largest AIDS Organization, Leading Southern California Latino AIDS Social Service Provider Offers Region s HIV/AIDS Patients Improved Access to Quality Care, Services in Greater El Monte EL MONTE, Calif., Dec. 17 /PRNewswire/ -- In an effort to better reach some under-served Los Angeles
PHILADELPHIA, Dec. 16 /PRNewswire/ -- Hemispherx Biopharma Inc. (Amex: HEB) has filed a US patent application (US Provisional No. 60/339,390) to develop a new immune-based treatment for HIV/AIDS. All of the approximately 18 existing approved therapies are antiretrovirals, and thus far uniformly directed only at the AID
BRISBANE, Calif., Dec. 16 /PRNewswire-FirstCall/ -- VaxGen , Inc. (Nasdaq: VXGN) announced today that the U.S. Food and Drug Administration ( FDA ) has designated HIV/AIDS vaccine candidates, AIDSVAX B/B and AIDSVAX B/E (rgp120), Fast Track Products for the prevention of HIV infection. The Fast Track designation will
WASHINGTON, Dec. 14 /PRNewswire/ -- The following is a transcript of remarks by President Bush: GOVERNOR RIDGE: Good afternoon. The President has just outlined the plan to strengthen the security of America by improving significantly our capability to protect Americans in the event of a small pox attack. As he describe
YONKERS, N.Y., Dec. 12 /PRNewswire-FirstCall/ -- Advanced Viral Research Corporation (OTC Bulletin Board: ADVR) today announced that the potential for Company s Product R as treatment for AIDS was the subject of a recent article in A&U Magazine. This global publication is devoted to collecting, archiving, publishin
WASHINGTON, Dec. 11 /PRNewswire/ -- At the invitation of President George W. Bush, President Daniel T. Arap Moi of Kenya and Prime Minister Meles Zenawi of Ethiopia met at the White House on Thursday, December 5, 2002. The leaders reaffirmed their strong commitment in the global war on terrorism.
NEW CANAAN, Conn., Dec. 11 /PRNewswire/ -- AmeriCares, the international disaster relief agency, today announced the launch of a humanitarian aid and disaster relief effort to deliver medicines and nutritional supplements to hospitals and clinics in southern Africa and Ethiopia . The first in a six- month series of Ame
BRIDGEWATER, N.J., Dec. 10 /PRNewswire/ -- Results of a new study published today in The Journal of the American Medical Association found that critically ill patients who received once weekly PROCRIT(R) (Epoetin alfa) were ten percent less likely to receive red blood cell transfusions (RBCs) than patients in the place
BRIDGEWATER, N.J., Dec. 10 /PRNewswire/ -- Results of a new study published today in The Journal of the American Medical Association found that critically ill patients who received once weekly PROCRIT(R) (Epoetin alfa) were ten percent less likely to receive red blood cell transfusions (RBCs) than patients in the place
STRASBOURG, France , Dec. 10 /PRNewswire-FirstCall/ -- Transgene announced today that it has entered into a collaborative agreement with the International AIDS Vaccine Initiative (IAVI) to manufacture pre-clinical lots of IAVI s constructs for a novel form of vaccine. These constructs, developed at the National Institu
WASHINGTON, Dec. 9 /PRNewswire/ -- The Government of Haiti signed this week an agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria, launching a program that will open a pipeline for grants totaling $67 million to the country over the next five years. It is the first such agreement for the Global Fund
ANNAPOLIS, Md., Dec. 9 /PRNewswire-FirstCall/ -- Mymetics Corporation today announced that the Company will present research findings on a new approach to treating HIV and other retroviral diseases at the 10th Conference on Retroviruses and Opportunistic Infections. Mymetics is testing a novel class of anti-retroviral
Historic Mandela SOS Concert to Take Place on Robben s Island in South Africa on February 2, 2003 CAPE TOWN, South Africa, Dec. 6 /PRNewswire/ -- Nelson Mandela s SOS has been answered. At a launch event today at the National Botanical Gardens in Cape Town, Nelson Mandela, supported by Archbishop Desmond Tutu, Oprah Wi
MCLEAN, Va., Dec. 5 /PRNewswire/ -- The Center for Patient Advocacy today released a survey of surgeons, operating room nurses and consumers which reveals that health care professionals have grave concerns about the reuse of single use medical devices and their impact on patient health and safety. These devices, such a
NEW YORK, Dec. 5 /PRNewswire/ -- Sundance Channel joins Viacom in a company-wide initiative to raise awareness about the ongoing global AIDS crisis. As part of its efforts, Sundance Channel will present acclaimed documentary films about living with AIDS on January 13th and 14th. Monte Bramer s Paul Monette: The Brink o
INDIANAPOLIS, Dec. 5 /PRNewswire-FirstCall/ -- Roche Diagnostics (Roche), based in Indianapolis, Ind., is pleased to announce that the U.S. Food and Drug Administration ( FDA ) has granted 510(k) clearance of the company s COBAS AmpliScreen System. The COBAS AmpliScreen System is intended for use in laboratories testin
-- Dr. Jerome P. Horwitz, Researcher Who First Discovered AZT in the 1960 s As A Possible Cancer-Fighting Drug Offers Letter Supporting AIDS Group s Effort to Invalidate Patent on AZT, Other HIV Drugs LONDON, Dec. 5 /PRNewswire/ -- The researcher who first demonstrated that the drug AZT (Retrovir(R) or zidovudine) supp
ANNAPOLIS, Md., Dec. 4 /PRNewswire-FirstCall/ -- Mymetics Corporation (OTC Bulletin Board: MYMX) today presented preclinical data at the International Feline Retrovirus Research Symposium demonstrating potent antiviral activity of five candidate compounds against FIV, the feline equivalent of HIV. The Mymetics peptides
NUTLEY, N.J., Dec. 3 /PRNewswire/ -- Roche announced today that the U.S. Food and Drug Administration ( FDA ) has approved combination therapy with Pegasys(R) (peginterferon alfa-2a), a pegylated interferon, and Copegus(TM) (ribavirin) for the treatment of adults with chronic hepatitis C who have compensated liver dise
CBL Global Corp., Wholly-Owned Subsidiary of Trinity Companies, Inc., To Provide Awareness and Prevention Education Through Major Employers In Mining and Other Global Industries BERKELEY, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Trinity Companies, Inc. ( Trinity Companies ) (OTC: TTYC), a publicly-held Utah Corporation
SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- Genetronics Inc. (Amex: GEB; Toronto) announced today that it has extended a collaborative agreement with Chiron Corporation (Nasdaq: CHIR), Emeryville, CA to conduct additional experiments using Electroporation, Genetronics proprietary technology, to test an HIV DNA vaccine.
WASHINGTON, Dec. 3 /PRNewswire/ -- The U.S. government has promised to World Vision and two other humanitarian organizations one of the largest emergency aid grants in history to help address the needs of people starving in southern Africa. The $100 million grant to World Vision, CARE, and Catholic Relief Services will
MUMBAI, Dec. 2 /PRNewswire Asia/ -- India s fight against AIDS received additional support today with a sponsorship from global reinsurer Swiss Re, under their Sharing Solutions programme, for an HIV education project in Mumbai. The project will be managed by the NGO PCI (Project Concern International) and locally impl
BALTIMORE, Dec. 2 /PRNewswire/ -- The U.S. Agency for International Development (USAID) in Russia has awarded a group led by Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP) a $25 million grant to help improve the health of Russians, a population with a sobering health burden that
TAMPA, Fla., Dec. 2 /PRNewswire/ -- Romark Laboratories announced today that the United States Food and Drug Administration ( FDA ) has approved Alinia(TM) (nitazoxanide) for Oral Suspension for treatment of children with diarrhea caused by Cryptosporidium parvum and Giardia lamblia. Alinia is the first and only drug
NEW YORK, Dec. 1 /PRNewswire-FirstCall/ -- Pfizer Inc and The Pfizer Foundation today announced new and expanded initiatives designed to address the growing threat to human health posed by the HIV/AIDS pandemic. On the second anniversary of their innovative Diflucan Partnership Program, Pfizer and the South African Min
BALTIMORE, Dec. 1 /PRNewswire/ -- Baltimore s interfaith community launched an HIV/AIDS awareness initiative on World AIDS Day, Sunday, December 1 at an ecumenical breakfast held at the New All Saints Roman Catholic Church, 4408 Liberty Heights Avenue. Clergy from across the city came together to pledge their support a
WASHINGTON, Dec. 1 /PRNewswire/ -- The following is a proclamation by the President: The HIV/AIDS pandemic has taken the lives of more than 20 million people and is projected to take millions more. On World AIDS Day, countries around the world are united to support the individuals, families, and communities affected by
LOS ANGELES, Nov. 29 /PRNewswire/ -- Larry Kramer, the award-winning playwright and ACT UP (AIDS Coalition to Unleash Power) founder, has lent his powerful voice in support of a lawsuit seeking to invalidate the patent for the life-saving drug AZT (Retrovir(R) or zidovudine), the first AIDS drug. London-based
WASHINGTON, Nov. 29 /PRNewswire/ -- A new online database of programs serving children affected by HIV/AIDS around the world will debut on World AIDS Day December 1, 2002. Database listings will include grassroots programs throughout the world that provide care and support to children affected, infected and orphaned by
NEW YORK, Nov. 26 /PRNewswire/ -- SHOWTIME will premiere its latest original picture BEHIND THE RED DOOR on Sunday January 12 at 8:00 PM ET/PT. The film stars Golden Globe(R)-winning actor Kiefer Sutherland ( 24, Lost Boys, Young Guns and the SHOWTIME ORIGINAL PICTURE A Soldier s Sweetheart ), Kyra Sedgwick ( Something
SEATTLE, Nov. 26 /PRNewswire/ -- Americans have little interest in helping children overseas orphaned by the AIDS pandemic, according to a national survey commissioned by World Vision, the international Christian humanitarian organization. While 41 percent said they might be open to supporting organizations addressing
NEW YORK, Nov. 26 /PRNewswire/ -- In advance of World AIDS Day, 1 December, the Joint United Nations Programme on HIV/AIDS and the World Health Organization have released the 2002 statistics on the global epidemic: By the end of this year, 5 million men, women and children worldwide will have become infected with HIV,
TARRYTOWN, N.Y., Nov. 26 /PRNewswire/ -- Bayer Corporation, acting through its Diagnostics Business Group, today announced that the U.S. Food and Drug Administration ( FDA ) has granted clearance for GuideLines(TM) 6.0 Rules(1), the next-generation interpretative software used with the TRUGENE(TM) HIV-1 Genotyping Test
SOUTH SAN FRANCISCO, Calif., Nov. 25 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced that the Florida Medicaid Program has initiated a benefit coverage policy for phenotypic and genotypic HIV drug resistance testing effective November 15, 2002. This brings the number of state Medicaid programs
PHILADELPHIA, Nov. 25 /PRNewswire-FirstCall/ -- Hemispherx Biopharma, Inc. (Amex: HEB) announced today that it will present expanded new interim data from the Phase IIB HIV Clinical Trials of its RNA-based Ampligen(R) in Structured Treatment Interruption (STI), at the Drug Development in Antiretroviral Research (DART)
- World AIDS day: 1 December 2002 Analysing the sales of a range of items that actively promote AIDS responsibility reveals that women would seem to be more proactive than their male counterparts when considering safe sex. Six times more women than men are buying underwear that has a secret pocket for a condom. The ran
SAN FRANCISCO, Nov. 22 /PRNewswire/ -- Several big name recording artists have joined the Levi s(R) Staying Alive Jacket campaign in an effort to raise funds and awareness to combat HIV/AIDS globally. The latest participants in the campaign are Dave Matthews and Michelle Branch. Matthews and Branch join a list of parti
GLASGOW, Scotland, Nov. 22 /PRNewswire-FirstCall/ -- Data from the largest-ever study of boosted protease inhibitors demonstrated that a high proportion of HIV patients taking an investigational boosted saquinavir regimen (saquinavir 1000 mg with ritonavir 100 mg BID) or
LOS ANGELES, Nov. 21 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the United States , today applauded two staged protests against British pharmaceutical giant GlaxoSmithKline (GSK)/ South Africa that were spearheaded by South Africa s Treatment Action Campaign (TAC).
WASHINGTON, Nov. 21 /PRNewswire/ -- BET today announced its plans to provide special programming to coincide with World AIDS Day, which will be commemorated globally on Sunday, December 1. In keeping with its commitment to provide quality programming from an African-American perspective, BET will televise programs gear
GLASGOW, United Kingdom , Nov. 21 /PRNewswire/ -- Results of the SOLO trial, an open-label, multi-center study evaluating the safety and efficacy of once-a-day (QD) dosing of the investigational protease inhibitor (PI) GW433908 (908) boosted with ritonavir (908/r) QD in antiretroviral therapy-naive
NEW YORK, Nov. 21 /PRNewswire/ -- A study released this week found among drug injectors, African Americans are five times as likely to get HIV than whites and Latinos are one-and-a-half times as likely. The study also found that 50 to 80 percent of needle drug users become hepatitis C positive within six to 12 months o
SAN DIEGO, Nov. 20 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) today announced that the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration has granted two new intended uses for Gen-Probe s licensed nucleic acid test (NAT) for the detection of human immunodef
GLASGOW, Scotland, Nov. 20 /PRNewswire/ -- A new clinical study found that individuals switching from a protease inhibitor (PI)- based regimen to a PI- sparing, NNRTI-based regimen using VIRAMUNE(R)( nevirapine ), sustained viral suppression and had improved triglyceride levels. Researchers also observed that individu
WALTHAM, Mass., Nov. 20 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms for pharmaceutical and health care issues, forecast today that chemokine modulators are likely to generate blockbuster sales because of their use in multiple disease drug markets. By far the greatest poten
EMERYVILLE, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Chiron Corporation (Nasdaq: CHIR) announced today that multi-year agreements have been signed with the primary blood collection organizations in the U.S. for supply, service and support of Chiron s Procleix(TM) HIV-1/HCV Assay and System. Details of the agreements w
EMERYVILLE, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Chiron Corporation (Nasdaq: CHIR) announced today that multi-year agreements have been signed with the primary blood collection organizations in the U.S. for supply, service and support of Chiron s Procleix(TM) HIV-1/HCV Assay and System. Details of the agreements w
DENVER, Nov. 18 /PRNewswire-FirstCall/ -- New research about the sexual activities and attitudes of students ages 18-24 is offering a positive look at what is really happening behind closed doors. The Smarter Sex Survey, an online survey of more than 1,000 students, has surprising results: they take sex and monogamy se
TETERBORO, N.J., Nov. 18 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated, (NYSE: DGX), the nation s leading provider of diagnostic testing, information and services, announced today that it is the first reference laboratory to commercially offer Roche Diagnostics new, FDA- approved AMPLICOR HIV-1 MONITOR(R) Te
GLASGOW, Scotland, Nov. 18 /PRNewswire-FirstCall/ -- Roche and Trimeris, Inc. (Nasdaq: TRMS) today announced data from a second pivotal Phase III study (TORO 2) demonstrating that FUZEON(TM) ( enfuvirtide ), in combination with other antiretrovirals, provided benefit to treatment-experienced HIV patients at 24 weeks re
RESEARCH TRIANGLE PARK, N.C., Nov. 15 /PRNewswire/ -- Earvin Magic Johnson is teaming up with GlaxoSmithKline (GSK) to bring hope, encouragement and awareness about HIV/AIDS to the African-American community, which has experienced a steep rise in the incidence of the disease in the last decade. Johnson and GSK anno
SOUTH SAN FRANCISCO, Calif., Nov. 14 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) announced today that the Company has signed a preferred provider agreement with Pfizer Inc. (NYSE: PFE). Under the terms of the agreement, ViroLogic becomes Pfizer s preferred supplier for HIV resistance testing technology and
YONKERS, N.Y., Nov. 14 /PRNewswire-FirstCall/ -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that it has initiated the single dose safety study which is the first phase of three Product R clinical trials in Israel . The Company also announced that it has retained Quintiles Transnational Cor
SEATTLE, Nov. 13 /PRNewswire/ -- Kaleidos Pharma, Inc., today announced a collaboration with the Division of AIDS, National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH). Under the terms of the agreement, NIH researchers will conduct a non-human primate study to evaluate the po
MONTREAL, Nov. 13 /PRNewswire/ - Pharmacor Inc. has been issued U.S. patent application no. 10/143,095, relating to its antiretroviral program. The small-molecule compounds described in the patent, entitled Urea derivatives as HIV aspartyl protease inhibitors , are next-generation anti-HIV lead molecules that demonstra
NEW YORK, Nov. 13 /PRNewswire/ -- Positive Health Project, a New York City syringe exchange program, and Diversified Health Systems Management, Inc., today announced the opening of Positive Health Care, the nation s first comprehensive health care center targeting high-risk clients, including current and former injecti
NEW YORK, Nov. 12 /PRNewswire/ -- The United Nations Foundation, in partnership with The Advertising Council, announced the launch of a new public service advertising (PSA) campaign designed to raise national awareness of the global AIDS epidemic and encourage all Americans to get involved in the fight against AIDS.
-- Most Sensitive Assay to Be Approved for Qualitative Detection Of HCV to Be Marketed by Bayer Diagnostics - SAN DIEGO, Nov. 8 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO), an established leader in molecular diagnostics based on its patented nucleic acid testing (NAT) technologies, today announced t
SAN FRANCISCO, Nov. 7 /PRNewswire/ -- I have HIV, and I have sex is the opening line of a bold new installment of the groundbreaking HIV STOPS WITH ME public health prevention campaign. Reaching out to people already infected with HIV, the campaign is due to launch this week on television and in print in San Francisco.
NEW YORK, Nov. 7 /PRNewswire/ -- EngenderHealth today announced that it has been awarded a $178,266 grant under The Pfizer Foundation s newly introduced International HIV/AIDS Health Literacy Grants program. This grant will enable EngenderHealth to start its project, Building a Common Literacy: Creating Bridges between
-- Magic Johnson, Congresswoman Loretta Sanchez, AIDS Healthcare Foundation Applaud Action on Potential Life-saving Tool: Broad Coalition of Public Officials, Health Organizations, AIDS Groups Now Call for Widespread Availability of Test WASHINGTON, Nov. 7 /PRNewswire/ -- Health and Human Services Secretary Tommy Thomp
ACCRA, Ghana , Nov. 6 /PRNewswire/ -- Muslim and Christian religious leaders will foster support and compassion for those living with HIV/AIDS under a new program launched today in Ghana, where approximately a half- million people are living with the virus that causes AIDS. Reach Out, Show Compassion for people living
WASHINGTON, Nov. 5 /PRNewswire/ -- The Biotechnology Industry Organization (BIO) today announced that Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and David L. Heymann, MD, executive director of communicable diseases for the World Health Organization (WHO),
-- Annual Meeting Makes Its International Debut in Toronto, Ontario, Canada on November 10-14; More than 7,500 Scientists to Attend ARLINGTON, Va., Nov. 4 /PRNewswire/ -- From effects of space on an astronaut s medications to a young scientist s dream of creating a healthier world for all races, the 2002 American Assoc
CHICAGO, Nov. 4 /PRNewswire-FirstCall/ -- The Female Health Company (OTC Bulletin Board: FHCO) today announced that it signed a contract with the Ministry of Health of Brazil to provide four million FC Female Condoms for the Ministry s groundbreaking National AIDS Program. Under the terms of the contract, two million u
DURHAM, N.C., Nov. 4, 2002 /PRNewswire-FirstCall/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) announced today that the U.S. Food and Drug Administration ( FDA ) has notified the Company that its New Drug Application (NDA) for marketing approval of Coviracil for the treatment of HIV disease has been accepted for fi
TAMPA, Fla., Nov. 4 /PRNewswire/ -- A study published in the November 2, 2002 issue of the British journal, The Lancet, showed that a new drug, nitazoxanide, significantly reduced the duration of diarrhea and the rate of death in malnourished children with Cryptosporidium infection. Cryptosporidium is a waterborne prot
-- University of Arizona College of Pharmacy, Arizona Cancer Center to Lead Research TUCSON, Ariz., Nov. 4 /PRNewswire/ -- The Procter & Gamble Company (NYSE: PG) today donated to the University of Arizona (UA) Foundation 33 patents and accompanying intellectual property related to a portfolio of compounds that hav
CHICAGO, Nov. 4 /PRNewswire/ -- Norzyme, Inc., developer of therapeutic drug monitoring technology for use at point-of-care, has launched clinical trials for its Levoprin-ZG(TM) product, developed to aid in the disease management of HIV-AIDS patients. Five universities are participating in the study, titled Measurement
HUNTINGDON VALLEY, Pa., Nov. 4 /PRNewswire/ -- Biosyn, Inc. announced today that the company, along with five collaborating partners, has been awarded a $10 million grant from the National Institutes of Health (NIH) for the development of a potent HIV-inhibiting compound, Cyanovirin-N, as a microbicide to prevent the s
WASHINGTON, Oct. 31 /PRNewswire/ -- Thousands of people with HIV/AIDS and their families will receive permanent housing and supportive services as a result of $12 million in grants announced today by Housing and Urban Development Secretary Mel Martinez. The renewal grants are part of HUD s Housing Opportunities for Per
Partnership Between Nation s Largest AIDS Organization, Respected Local Social Service Provider Offers Region s HIV/AIDS Patients Improved Access to Quality Care, Services in South Bay REDONDO BEACH, Calif., Oct. 31 /PRNewswire/ -- In an effort to better reach some under-served Los Angeles County residents with quality
LOS ANGELES, Oct. 30 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR) announced today the results of the company s first Scientific Advisory Board (SAB) meeting. The meeting was chaired by Dr. Louis Ignarro, 1998 Nobel Laureate in medicine, and took place on Thursday, October 17th in Los Angeles, California. The SAB of
SAN FRANCISCO, Oct. 30 /PRNewswire/ -- ChevronTexaco Corp. (NYSE: CVX) today welcomed the official launch of A Day in the Life of Africa, the latest release in the best-selling A Day in the Life photo documentary series. ChevronTexaco is an underwriting partner of the project -- which includes a book, DVD documentary a
EDEN PRAIRIE, Minn., Oct. 28 /PRNewswire/ -- American TeleCare, Inc. (ATI) announced today that HHC Health & Home Care, a division of New York City Health & Hospitals Corporation, has implemented the first home telehealth program that targets patients who are HIV positive. In March 2002, HHC purchased 59 of ATI
-- News, Solid Reporting and Dateline Format Drawing Gay and Straight Listeners Alike To Life OUTside on 70 Radio Stations Nationwide Plus Internet CHICAGO, Oct. 28 /PRNewswire/ -- Once relegated to local community newspapers, during the past decade, gay-themed programming and media have grown exponentially to now reac
-- Actor James Woods Hosts Program Featuring Children Who Relate Their Personal Experiences With HIV/AIDS; Another Examines the Impact of this Devastating Epidemic on Our Society BETHESDA, Md., Oct. 28 /PRNewswire/ -- Although the growth of the ongoing AIDS epidemic has wrought a terrible physical and emotional toll, m
SEATTLE and BALTIMORE, Oct 28 /PRNewswire/ -- The Bill & Melinda Gates Foundation will contribute $3 million to the Johns Hopkins University School of Medicine for the development of community-based preventive strategies to control tuberculosis (TB) in areas around the world with severe HIV epidemics. The grant wil
SEATTLE and RESEARCH TRIANGLE PARK, N.C., Oct. 28 /PRNewswire/ -- The Bill & Melinda Gates Foundation announced today that it has awarded Family Health International (FHI) a $6.5 million, three-year grant for a multinational clinical trial to evaluate an antiretroviral treatment as a novel approach to HIV preventio
At-A-Glance -- 299 HIV+, treatment-experienced people participated in the survey -- Multiple factors impact a patient s adherence to a HAART treatment regimen exactly as prescribed. -- Total number of pills in a regimen has the greatest impact on adherence of 10 attributes studied in a survey on treatment adherence.
-- HIV Infection, Street Drugs and HIV Medications Cited as Leading Causes - CHICAGO, Oct. 25 /PRNewswire/ -- Key findings of a national physician and patient survey conducted by the International Association of Physicians in AIDS Care (IAPAC) demonstrate a strong link between HIV infection and the mental health of pat
-- Sean P. Diddy Combs to Perform in Cape Town & Michelle Branch in Seattle as Part of HIV/AIDS Awareness Concerts To Premiere on MTV Globally as 90-Minute Special on World AIDS Day -- More Than 60 Broadcasters Worldwide Confirmed to Air Concert & Other HIV/AIDS Awareness Programming Rights Free CAPE TOWN,
-- Medication Noncompliance Increases Health Problems and Escalates Healthcare Costs WINSTON-SALEM, N.C., Oct. 25 /PRNewswire-FirstCall/ -- ALR Technologies (OTC Bulletin Board: ALRT), manufacturer of an affordable, easy-to-use medication reminder called the ALRT Med Reminder, announced at a meeting this week in Winsto
- VALTREX Prolonged Length of Time To First Recurrence of Genital Herpes CHICAGO, Oct. 25 /PRNewswire/ -- Twice daily treatment with VALTREX(R) (valacyclovir HCl) caplets is effective in suppressing genital herpes recurrences in HIV-infected patients, according to data presented at the Infectious Diseases Society of Am
LOS ANGELES, Oct. 24 /PRNewswire/ -- A broad, growing coalition of public health officials, health organizations, and HIV/AIDS groups are calling for widespread availability of new rapid HIV tests through a waived status under the Clinical Laboratories Improvement Act (CLIA). Supporters include President Bush s Advisor
-- The Month-Long 102.9 WMGK Classic Rock Art Show and Silent Auction Opens To The Public on Friday, November 15 and Will Benefit the Elizabeth Glaser Pediatric AIDS Foundation PHILADELPHIA, Oct. 23 /PRNewswire/ -- WMGK (102.9FM/Philadelphia) will showcase a never-before seen collection of original art and lithographs,
-- Company s Proprietary Peptide Technology Offers Potential Alternative to Standard Treatment Regimens WOODLAND HILLS, Calif., Oct. 23 /PRNewswire/ -- Zengen, Inc. announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration for CZEN 002, one of the Company
-- Information for SILCAAT Patients and Clinicians Available Toll Free At 1-866-874-3153 EMERYVILLE, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Chiron Corporation (Nasdaq: CHIR) announced today decisions on three clinical development programs. Chiron is stopping SILCAAT, a Phase III study for recombinant human interleuk
EAGAN, Minn., Oct. 23 /PRNewswire/ -- Regular dental visits may help maintain better oral health in people with the Human Immunodeficiency Virus (HIV), suggests a study conducted by Delta Dental Plan of Minnesota researchers and published as the cover story in the October issue of the Journal of the American Dental Ass
- More Convenient Dosage of OXANDRIN May Enhance Patient Compliance ISELIN, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Today Bio-Technology General Corp. (Nasdaq: BTGC) announced the availability of the new 10mg strength of OXANDRIN(R) (oxandrolone, USP - CIII) a treatment for involuntary weight loss which can be associat
WASHINGTON, Oct. 21 /PRNewswire/ -- The following are remarks by the President on Prescription Drugs: The Rose Garden 8:33 A.M. EDT THE PRESIDENT: Good morning. For more than a year, the Federal Trade Commission has investigated delays and abuses in the process of bringing generic drugs to the market. I have reviewed t
ROSEVILLE, Minn., Oct. 21 /PRNewswire/ -- A new powerful drug against AIDS, known as STAMPIDINE, was developed at the Parker Hughes Center for Clinical Immunology. The effectiveness of this drug was tested first in the test tube against drug-resistant AIDS virus isolates from 29 different HIV- infected individuals. Thi
BRISBANE, Calif., Oct. 21 /PRNewswire-FirstCall/ -- The independent board that oversees VaxGen , Inc. s clinical trials completed the final safety and conduct review of the company s Phase III trial in Thailand and once again concluded that the study was being conducted appropriately and that VaxGen s AIDS vaccine cand
SOUTH SAN FRANCISCO, Calif., Oct. 21 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) and Surveillance Data, Inc. (SDI), announced today that the companies have signed an agreement to create a new line of HIV market research products based on data collected through ViroLogic s HIV resistance testing and therapy
WASHINGTON, Oct. 16 /PRNewswire/ -- A new scientific report released today reveals that condoms, even when used 100 percent of the time, fail to reduce the risk of some of the most common and potentially dangerous sexually transmitted diseases (STDs) to an acceptable level. Sex, Condoms, and STDs: What We Now Know, rel
SAN DIEGO, Oct. 15 /PRNewswire/ -- Immusol, The Inverse Genomics(TM) Co., announced that Discover Magazine has recognized Dr. Flossie Wong-Staal, Immusol s Chief Scientific Officer and Vice President of Genomics, as one of 50 most extraordinary women scientists across all disciplines. Selection of the top women scienti
MONTREAL, Oct. 15 /PRNewswire-FirstCall/ - Pharmacor announces the discovery of a new class of drug-like compounds in its battle against drug- resistant HIV. The exceptional characteristic of these compounds is that they are significantly more active against protease-inhibitor (PI) resistant strains than against the co
WINSTON-SALEM, N.C., Oct. 15 /PRNewswire/ -- Patients undergoing treatment for the HIV virus have benefited from a new medication reminder that prompts them to take their medications on time, as prescribed, according to feedback from physicians who have given reminders to their patients. The positive, anecdotal results
- Nation s Largest AIDS Organization Discovers Glaxo Smoking Gun: British Drug Maker Lied to Get AZT Patent NEW YORK, Oct. 15 /PRNewswire/ -- The largest AIDS organization in the United States today announced that it has filed an amended federal anti-trust complaint against British-owned G
- Global Health Action Collaborates With Chinese Health and Government Agencies to Address Domestic Abuse, HIV/AIDS Infection and Women s Reproductive Health Issues ATLANTA, Oct. 15 /PRNewswire/ -- Global Health Action (GHA), a nonprofit health education and leadership and management development organization headquarte
- Findings Presented at Meeting of the American Association for Cancer Research Show That Product R Induces Differentiation of a Human Promyelocytic Leukemia Cell Line YONKERS, N.Y., Oct. 11 /PRNewswire-FirstCall/ -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that the Company s peptide nuc
- 1,400-Patient Sample Study Demonstrates Phenotypic and Genotypic Assays Provide Complementary Information Critical for Optimum Treatment SOUTH SAN FRANCISCO, Calif., Oct. 11 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced that study results published in the current issue of the Journal of Acq
NUTLEY, N.J. and DURHAM, N.C., October 11 /PRNewswire-FirstCall/ -- Roche and Trimeris, Inc. (Nasdaq: TRMS) today announced that the U.S. Food and Drug Administration ( FDA ) has notified the companies that the New Drug Application (NDA) for FUZEON(TM) (generic: enfuvirtide , formerl
LAS VEGAS, Oct. 10 /PRNewswire/ -- Women infected with HIV who develop a treatment plan with both their pediatrician and obstetrician during pregnancy reduce the impact of the virus on themselves and their unborn baby, Ronald J. Librizzi, D.O., an osteopathic obstetrician and gynecologist, reported at the American Oste
MONTREAL, Oct. 10 /PRNewswire/ - URRMA Biopharma Inc. ( URRMA ) is pleased to announce the US Food and Drug Administration ( FDA ) has granted approval of URRMA s Investigational Device Exemption (IDE) application for the Anti-R7V Diagnostic Kit. This is equivalent to a Phase II in the more commonly used terminology pe
SAN DIEGO, Oct. 9 /PRNewswire/ -- Chimerix, Inc., an emerging biotechnology company developing orally available, targeted medicines from bioactive molecules, today announced the appointment of George Painter, Ph.D. as company President and CEO. Dr. Painter has twenty-four years of experience in the discovery and develo
- Worldwide Initiative to Foster HIV/AIDS Awareness and Prevention Through PSAs, Television and Radio Programming, and Outdoor, Print and Online Content NEW YORK, Oct. 9 /PRNewswire/ -- Viacom Inc. and the Henry J. Kaiser Family Foundation today announced a comprehensive global media campaign beginning January 6, 2003
SEATTLE, Oct. 6 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced that its co-founder, Bill Gates, will visit India next month to lead a foundation delegation that will see first-hand some of the challenges and exemplary initiatives underway to prevent the transmission of HIV. During his trip, Ga
SAN DIEGO, Oct. 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) an established leader in molecular diagnostics based on its patented nucleic acid testing (NAT) technologies, today announced that it has received $1.0 million from the National Heart, Lung and Blood Institute (NHLBI) of the National Inst
- MTV, Levi s(R) Brand, Bill & Melinda Gates Foundation, Paul G. Allen Charitable Foundation, Population Services International s YouthAIDS & UNAIDS Form Unprecedented HIV/AIDS Awareness Partnership For Youth - All HIV/AIDS Awareness Programming & PSAs Available Rights Free to All Broadcasters Worldwide
- As Government Limits Pharmaceutical Marketing Practices That Skirt Federal Fraud and Abuse Laws, Nation s Largest AIDS Organization Demands That Drug Price Reductions Accompany New Regulations LOS ANGELES, Oct. 2 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the nation s largest specialized provider of HIV/AIDS m
MENLO PARK, Calif., Oct. 2 /PRNewswire/ -- SLIL Biomedical Corp. today announced the publication of seminal Sequential Pathogenesis research, conducted by UCSF scientists, SLIL Biomedical researchers and academic collaborators, in the October issue of Cancer Research. The study found that macrophages, normally key immu
MADISON, Wis., Oct. 2 /PRNewswire/ -- EraGen Biosciences, a growing life science company, commented today on the relationship between its AEGIS(TM) nucleic acid technology and the recent US Food and Drug Administration ( FDA ) approval of Bayer Diagnostics VERSANT(R) HIV-1 RNA 3.0 Assay (bDNA). The Versant(R) Assay ha
ABBOTT PARK, Ill., Oct. 2 /PRNewswire-FirstCall/ -- Abbott Laboratories (NYSE: ABT) Kaletra (R) ( lopinavir / ritonavir ) has become the most-prescribed protease inhibitor (PI) as part of a treatment regimen for HIV in the
BOTHELL, Wash., Oct. 1 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced it has reacquired all product, patent, trademark, licensing and regulatory rights for Nascobal(R) in the United States from Schwarz Pharma. Under terms of the acquisition agreement, Nastech will pay Schwarz a t
- Findings Also Suggest Reduction in Cardiovascular Risk Factors Associated with Condition ROCKLAND, Mass., Sept. 30 /PRNewswire-FirstCall/ -- Serono S.A. (virt-x: SEO and NYSE: SRA) announced 24-week results from a completed clinical trial of Serostim(R) [somatropin (rDNA origin) for injection] evaluating the treatmen
SAN DIEGO, Sept. 30 /PRNewswire-FirstCall/ -- Data presented today at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy in San Diego reveal that for patients co-infected with Hepatitis-C (HCV) and HIV, VIRACEPT(R) (nelfinavir mesylate) is generally well tolerated. The retrospective analysis, con
SOUTH SAN FRANCISCO, Calif., Sept. 30 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) announced that results of four studies demonstrating the benefits of its HIV drug resistance products and technologies were presented today at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
- Representative Lead Pre-clinical Compound Developed To Combat HIV Drug Resistance Using Novel Target SAN DIEGO, Calif., Sept. 30 /PRNewswire/ -- Achillion Pharmaceuticals announced the development of a new class of compounds that inhibits a broad spectrum of drug-resistant HIV strains by targeting a novel virus prote
SAN DIEGO, Sept. 28 /PRNewswire/ -- Demonstrating encouraging advances in the treatment of chronic hepatitis B virus (HBV) infection, researchers at Beth Israel Deaconess today presented the first clinical data for Beta-L-Fd4C (ACH-126,443), Achillion Pharmaceuticals novel L-nucleoside. In the blinded, placebo controll
SAN DIEGO -- A study presented today at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Diego, California showed that a regimen containing the investigational protease inhibitor atazanavir provided antiviral effect comparable to a standard-of-care regimen containing SUSTIVA(R) (
SAN DIEGO -- Roche and Trimeris (NASDAQ: TRMS) today announced new data from a Phase III pivotal study demonstrating that regardless of patient demographics or treatment history, FUZEON(TM) (generic: enfuvirtide , formerly known as T-20) in combination with other antiretrovirals provided benefit to treatment-experience
SAN DIEGO, Sept. 27 /PRNewswire/ -- Six HIV and AIDS researchers will split $500,000 as this year s recipients of the GlaxoSmithKline (GSK) Drug Discovery and Development Award. The unrestricted research award program is funded by GSK to support independent, innovative and novel research in the development of HIV/AIDS
SAN DIEGO -- According to study data presented at the 42nd ICAAC, the Interscience Conference on Antimicrobial Agents and Chemotherapy, once-daily suppressive therapy with VALTREX(R) (valacyclovir HCl) caplets reduced transmission of symptomatic genital herpes (a visible outbreak) by 77 percent in healthy heterosexual
SAN DIEGO -- A study from The Feinberg School of Medicine has shown that the protease inhibitor lopinavir / ritonavir ( Kaletra (R)) suppressed HIV to undetectable levels and was well tolerated through four years of treatment in patients who had not
PRINCETON, N.J. -- Bristol-Myers Squibb Company (NYSE: BMY) has started enrolling patients in an early access program to provide the investigational protease inhibitor, atazanavir, to eligible patients infected with HIV. An early access program (EAP) provides medicines to eligible patients in need of alternative therap
SAN DIEGO -- Triangle Pharmaceuticals, Inc. (NASDAQ: VIRS) presented data at the Late Breaker Session at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) which showed that Coviracil (emtricitabine) was statistically superior to Zerit (
ANNAPOLIS, Md. -- Mymetics Corporation (BULLETIN BOARD: MYMX) today presented preclinical data at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) on two novel gp41-derived peptide candidates that demonstrate potent inhibition of HIV in vitro. Both peptides were developed to disrupt a phenom
SAN DIEGO -- Roche today announced results of two studies examining the lipid safety profile of twice-daily boosted saquinavir (1000 mg saquinavir with 100 mg ritonavir ) for HIV. Data from the first head-to-head study of boosted protease inhibitors (the MaxCmin1 trial) revealed that boosted saq
SAN DIEGO -- Results of the NEAT trial, an open-label, multi-center study evaluating the safety and efficacy of the investigational protease inhibitor (PI) GW433908 (908) in antiretroviral therapy-naive patients versus nelfinavir (NFV, Viracept (R)), were presented here today at the 42nd Interscience Conference on Anti
- Program Designed to Expand Employee Healthcare to Include AIDS Testing And Drug Treatment That Will Start in Southern and Eastern Africa MANZINI, Swaziland , Sept. 26 /PRNewswire/ -- The Coca-Cola Africa Foundation announced today that it is joining with Coca-Cola s 40 bottlers in Africa to help them expand their emp
SOUTH SAN FRANCISCO, Calif., Sept. 26 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced that four presentations related to its novel drug resistance products and technology will be made at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) taking place at the San Di
- Program designed to Expand Employee Healthcare Include Prevention, AIDS Testing and Drug Treatment that will start in Southern and Eastern Africa AMSTERDAM, Netherlands , Sept. 26 /PRNewswire/ -- PharmAccess International announced today that it will participate in a program to expand employee healthcare in collabora
- Culmination of 16 Year Hunt Suggests New Therapeutic Strategies in AIDS - FREMONT, Calif., Sept. 26 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (Nasdaq: CIPH) today announced an important discovery made using their proprietary protein analysis technology: the long-awaited identification of the CD8+ Antiviral
ALAMEDA, Calif. -- Calypte Biomedical Corporation (BULLETIN BOARD: CALY) , the developer and marketer of the only two FDA approved HIV-1 antibody tests for use with urine samples, shared information about the benefits and performance of its urine HIV-1 tests at the United States Conference on AIDS (USCA) h
ARLINGTON, Va., Sept. 24 /PRNewswire/ -- FireLogic, Inc. today introduced the next generation of its innovative HealthEngage disease management software. HealthEngage provides an easy to use, yet comprehensive tool for patients to manage their wellbeing from any desktop or handheld computer. Using HealthEngage, patient
ATLANTA, Sept. 24 /PRNewswire/ -- Pharmasset, Inc. is pleased to announce its sponsorship of the 2nd annual Georgia Life Sciences Summit -- From Bench to Blockbuster. This event, which is considered the primary gathering of scientists and industry decision makers for Georgia s life sciences community, will take place o
WOODRIDGE, Ill., Sept. 24 /PRNewswire/ -- The U.S. Patent and Trademark Office issued a broad patent to Sarawak MediChem Pharmaceuticals of Woodridge, Ill., bolstering the company s proprietary position in the use of calanolides as potential anti-viral drugs, the company announced today. Sarawak MediChem Pharmaceutical
DETROIT, Sept. 23 /PRNewswire/ -- The city of Detroit AIDS Walk is a unique collaboration of 25 service organizations in the Detroit area that will host their 4th annual AIDS Walk on Detroit s Belle Isle, Saturday, September 28, 2002. Registration begins at 10 a.m. with the 5K walk scheduled to start at noon come rain
AMSTERDAM, Netherlands , Sept. 23 /PRNewswire/ -- Primagen Holding B.V. announced today that they have extended their service testing agreement with Gilead Sciences , Inc., to measure mitochondrial DNA using the Retina(TM) Mitox test in samples of a multi-year, multi-center phase III clinical study of
DENVER, Sept. 23 /PRNewswire/ -- Invenux, Inc. announced today that the company was awarded an SBIR grant of $100,000 from the National Institutes of Health to begin a drug-discovery program aimed at producing novel anti-HIV agents. The phase I study will involve the initiation of a program to generate a small molecule
-- First Nucleotide Analogue for the Treatment of Chronic Hepatitis B : Second Novel Gilead Antiviral Approved in Less than One Year - FOSTER CITY, Calif., Sept. 23 /PRNewswire-FirstCall/-- Gilead Sciences (Nasdaq: GILD) today announced that it received U.S. Food and Drug Administration ( F
- Finding Based on Clinical Trial of New Treatment Developed by BDSI - NEWARK, N.J., Sept. 23 /PRNewswire-FirstCall/ -- A clinical trial by researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) has shown a new autologous immunotherapy appears to be safe and effective treatment for controlling HI
-- State-of-the-Art AIDS Healthcare Foundation Facility Offers San Franciscans Improved Access to Quality Care, Services SAN FRANCISCO, Sept. 20 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the nation s largest provider of specialized HIV/AIDS medical care, is pleased to announce that basketball legend Earvin Mag
NUTLEY, N.J. and DURHAM, N.C., Sept. 20 /PRNewswire-FirstCall/ -- Roche and Trimeris, Inc. (Nasdaq: TRMS) today announced the submission of a Marketing Authorization Application to the European Union (EU) for FUZEON(TM) ( enfuvirtide ), formerly known as T-20, for HIV-1 infection in combination with other antiretrovira
- Survivor Props, Memorabilia, Experience Packages and Castaway Phone Calls To Be Offered on eBay to Benefit the Elizabeth Glaser Pediatric AIDS Foundation SANTA MONICA, Calif., Sept. 19 /PRNewswire/ -- Get ready for a whole new season of Survivor and your chance to own a piece of television history. Ever wondered what
ANNAPOLIS, Md., Sept. 19 /PRNewswire-FirstCall/ -- Mymetics Corporation (OTC Bulletin Board: MYMX), an international biotechnology firm focused on molecular mimicry and retroviral diseases, announced today the appointment of its senior management team and scientific advisory board. The senior management includes Peter
ALAMEDA, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, announced today that the West Virginia Office of the Insurance Commissioner has cleared the way f
BRISBANE, Calif., Sept. 18 /PRNewswire-FirstCall/ -- VaxGen , Inc. (Nasdaq: VXGN) is scheduled to present at the UBS Warburg Global Life Sciences Conference at 4 p.m. Eastern time, Oct. 8, 2002 at the Plaza Hotel in New York. Lance K. Gordon, Ph.D., VaxGen s CEO, will represent VaxGen at the conference. Dr. Gordon
- Action on Assemblyman Paul Koretz s (D, West Hollywood) Bill Received Overwhelming Editorial Support From State s Top Newspapers, Called Most Important AIDS Policy Bill Nationwide This Year, By AIDS Healthcare Foundation President Michael Weinstein LOS ANGELES, Sept. 18 /PRNewswire/ -- Honoring a campaign pledge made
TORONTO, Sept. 18 /PRNewswire-FirstCall/ -- Polydex Pharmaceuticals Ltd. (Nasdaq: POLXF) announces continued progress in the development of Ushercell, the patented lead development product for Polydex. Ushercell has completed three Phase I/II clinical trials and further Phase I/II clinical trials are ongoing. Ushercell
DURHAM, N.C., Sept. 17, 2002 /PRNewswire-FirstCall/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) today announced the final settlement of patent disputes involving Triangle s drug candidate amdoxovir. Amdoxovir is a purine nucleoside analogue for the treatment of HIV disease. Triangle licensed amdoxovir from Emory U
- AIDS Healthcare Foundation Praises Thirty California Representatives Joining Mary Bono, Henry Waxman, Doug Ose, and Diane Watson in Effort to Boost AIDS Drug Assistance Program (ADAP) LOS ANGELES, Sept. 17 /PRNewswire/ -- Thirty of California s representatives in Congress today joined across party lines to ask House
FERNDALE, Mich., Sept. 17 /PRNewswire/ -- Over 200 of Detroit s most prominent artists will donate original pieces of art to be auctioned at the eighth annual ART WORKS FOR LIFE. This exciting event will begin at 6:30 p.m. on Saturday, September 28, 2002 at the Edsel and Eleanor Ford House in Grosse Pointe Shores to be
WASHINGTON, Sept. 17 /PRNewswire-FirstCall/ -- The Constituency for Africa (CFA) recently presented DaimlerChrysler AG with its Corporate Leadership Award in recognition of the company s commitment to combating the HIV/AIDS Pandemic in Africa. The award was presented at the organization s annual awards ceremony last we
WHO: Teens will test their tech and fashion flair at Microsoft s Outsmart Encarta and Strike a Pose stages at Macy s Passport 20/02. Teens will model their quest for knowledge by offering smart answers to shock jock Strawberry from WILD 94.9, who will ask some tough trivia questions at the Outsmart Encarta stage.
TARRYTOWN, N.Y., Sept. 17 /PRNewswire/ -- Bayer Diagnostics announced today that it received US Food and Drug Administration approval for VERSANT(R) HIV-1 RNA 3.0 Assay (bDNA)*, its nucleic acid probe diagnostic assay for the direct quantification of HIV-1 RNA in the plasma of people living with HIV. VERSANT(R) HIV bDN
NUTLEY, N.J. and DURHAM, N.C., Sept. 17 /PRNewswire-FirstCall/ -- Roche and Trimeris, Inc. (Nasdaq: TRMS) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration ( FDA ) for approval to market FUZEON(TM) ( enfuvirtide ), formerly known as T-20.
WASHINGTON, Sept. 16 /PRNewswire/ -- An unintended casualty of last year s horrific events of September 11 was the cancellation of the 2001 United States Conference on AIDS scheduled to begin just two days later in Miami Beach. For the first time since that fateful day, HIV/AIDS treatment leaders, advocates and front-l
ALBANY, N.Y., Sept. 16 /PRNewswire/ -- Delmar Learning, a leader in educational resources for lifelong learning and part of The Thomson Corporation (NYSE: TOC; TSX: TOC), today announced the release of the latest editions of health care facilities handbooks covering OSHA and OBRA guidelines. The third edition of The OS
WASHINGTON, Sept. 13 /PRNewswire/ -- Pharmaceutical and biotechnology companies are working on 249 new medicines for diseases that disproportionately afflict African Americans or diseases that are among the top 10 causes of death among African Americans, according to a new survey by the Pharmaceutical Research and Manu
WHO: DAME ELIZABETH TAYLOR hosts Macy s Passport 20/02 s Gala Evening on September 19, America s premier HIV/AIDS fundraiser and fashion show featuring the best of Macy s fall collections for men, women and children. Presented by American Express, this year the show includes a special performance by classical violinist
ALAMEDA, Calif., Sept. 12 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CALY), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, said the company will attend the United States Conference on AIDS (USCA) in Anaheim, CA, Sept
VANCOUVER, Sept. 12 /PRNewswire-FirstCall/ - Micrologix Biotech Inc. (TSX: MBI; US OTC: MGIXF) has acquired a broad portfolio of antiviral technologies and product candidates (the Portfolio ) formerly owned and/or being developed by Origenix Technologies Inc. (the Origenix Intellectual Property ). These technologies an
NEWARK, N.J., Sept. 12 /PRNewswire-FirstCall/ -- BioDelivery Sciences International (Nasdaq: BDSI; BDSIW) announced today that they have received a two year $600,000 National Institutes of Health (NIH) SBIR Grant to develop an oral form of a powerful HIV prophylactic/therapeutic vaccine with their patented Bioral(TM) d
ROYAL OAK, Mich., Sept. 10 /PRNewswire/ -- AIDS Walk Detroit has hit the streets with its 2002 campaign, Real People. Real Stories. As part of this campaign, 5 area residents whose lives have been touched by HIV and AIDS are telling their stories in support of the September 15 Walk. They include, Bill, an HIV positive
BRUSSELS, Belgium , Sept 10 /PRNewswire/ -- Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key US patent in the area of HIV infection. The patent claims a specific GPCR sequence included in the human CCR5 receptor. The CCR5 receptor has a central role in the mecha
CARLSBAD, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Signaling a move to restructure and reposition the Company for potential product commercialization, The Immune Response Corporation (Nasdaq: IMNR) announced today a restructuring program and management changes aimed at reducing costs and refocusing the Company on its
WALTHAM, Mass., Sept. 9 /PRNewswire/ -- Decision Resources, Inc., one of the world s leading research and advisory firms focusing on pharmaceutical and health care issues, announced today that the expanding multi-resistant HIV population is in need of new classes of drugs. One such drug that could prove valuable to the
- AIDS Healthcare Foundation Says Tragic Glaxo Decision Won t Save Lives, Denounces Cynical P.R. Effort Against Lawsuit LOS ANGELES, Sept. 6 /PRNewswire/ -- The United States largest AIDS organization described yesterday s AIDS drug price reduction announcement by British-owned GlaxoSmithKline a hollow gesture th
ROYAL OAK, Mich., Sept. 6 /PRNewswire/ -- AIDS Walk Detroit has hit the streets with its 2002 campaign, Real People. Real Stories. As part of this campaign, 5 area residents whose lives have been touched by HIV and AIDS are telling their stories in support of the September 15 Walk. They include, Yvette, whose father, J
ATLANTA, Sept. 6 /PRNewswire/ -- Results from the scientific study, HEDS UP (HIV Early Detection Study of Unrecognized Positives), will be unveiled at a national HIV/AIDS Conference on Friday, Oct. 11 and Saturday, Oct. 12 at the Swissotel in Buckhead. The HEDS UP study found that 40 percent of patients diagnosed with
SAN DIEGO, Sept. 5 /PRNewswire/ -- Gen-Probe Incorporated, an established leader in molecular diagnostics based on its patented nucleic acid testing ( NAT ) technologies, today announced results from the initial field evaluation (beta trial) of the Company s TIGRIS System for clinical diagnostic testing. Two applicatio
-Patients taking medications for HIV were more likely to miss doses or take doses later following the events of 9/11, according to a study from the Center for HIV Educational Research and Training (CHEST) published on GayHealth.com NEW YORK, Sept. 5 /PRNewswire/ -- Gay and bisexual men with HIV on HAART (Highly Active
DURHAM, N.C., Sept. 4, 2002 /PRNewswire-FirstCall/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) announced today submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration for marketing approval of Coviracil for the treatment of HIV disease. Coviracil is a potent, once-a-day Nucleoside Rever
ALAMEDA, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, announced today that HIV pioneer Professor Luc Montagnier, co-discoverer of HIV-1 and discoverer o
PHILADELPHIA, Sept. 3 /PRNewswire-FirstCall/ -- Hemispherx Biopharma, Inc. (Amex: HEB), a biopharmaceutical company focused in the experimental-stage development of immune-based therapies primarily addressing the diseases of HIV AIDS and Chronic Fatigue Syndrome, today announced that Dr. William Carter, Chairman and CE
MELBOURNE, Australia , Sept. 3 /PRNewswire-FirstCall/ -- * Milestone in Australian HIV drug development with new study piggy-backing on current VIR201 treatment trial * Now testing VIR201 as independent therapy without accompanying anti-retroviral medications * New medication may provide relief from rigid routine and p
NEW YORK, Aug. 30 /PRNewswire/ -- Last night, MTV: Music Television and the Kaiser Family Foundation accepted a National Emmy Award for Be Safe/Fight for Your Rights: Protect Yourself, a national public education campaign that informs young people about sexual health issues such as HIV/AIDS and STDs via public service
MIAMI, Aug. 29 /PRNewswire/ -- While historically surgeons have been reluctant to transplant patients with the human immunodeficiency virus (HIV), in recent years, some centers have begun to accept patients with well- controlled HIV as candidates for liver or kidney transplantation. Based on results of three studies fr
NEW YORK, Aug. 29 /PRNewswire/ -- Reality TV used to evoke open and honest discussions about race, a campaign that tells the importance adults play in a child s education and an awareness program about HIV and sexual health issues were honored last night as the National Academy of Television Arts & Sciences present
-Grants Totaling $48 Million to Fund Research and Development of New Approaches To Contraception and Disease Prevention SEATTLE, Aug. 28 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced a series of grants that will combine innovative uses of existing tools with research and development of technol
-Law Enables Community-based, Nonprofit Organizations With Demonstrated Expertise to Conduct Counselor Training for State s HIV Testing Programs -AIDS Healthcare Foundation Gears Up to Target Hard-to-Reach Populations in Sex Clubs, Bath Houses and Via Mobile Testing Van -Preliminary July 2002 Alternative Testing Site R
ROYAL OAK, Mich., Aug. 28 /PRNewswire/ -- AIDS Walk Detroit has hit the streets with its 2002 campaign, Real People. Real Stories. As part of this campaign, 5 area residents whose lives have been touched by HIV and AIDS are telling their stories in support of the September 15 Walk to be held in Downtown Royal Oak. They
Company Extends Its Fusion Inhibitor Technology to New Viral Target GAITHERSBURG, Md., Aug. 28 /PRNewswire/ -- Panacos Pharmaceuticals, Inc. today announced that it has been awarded a Phase I Small Business Innovative Research (SBIR) Grant of $143,000 by the National Institutes of Health (NIH). The award will help supp
ALAMEDA, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CALY) the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, today announced that based upon positive preliminary results which have yielded 100 percent specifi
ANNAPOLIS, Md., Aug. 27 /PRNewswire-FirstCall/ -- Mymetics Corporation (OTC Bulletin Board: MYMX) today announced that the first major poster presentation of the Company s new approach to treating HIV and other retroviral diseases will take place next month at the Interscience Conference on Antimicrobial Agents and Che
ROYAL OAK, Mich., Aug. 26 /PRNewswire/ -- Royal Oak based bd s mongolian barbeque, a chain of restaurants with 28 locations spread across 12 states, celebrated its 10 year anniversary on Thursday, August 22, 2002 with an invitation only party at its Royal Oak establishment. At the event, Billy Downs, owner and founder
- Talk Show Host Cristina Saralegui, the Latin Oprah, to Accept HRC Civil Rights Award - Rep. Richard Gephardt, D-Mo., is Featured Speaker WASHINGTON, Aug. 26 /PRNewswire/ -- The Human Rights Campaign proudly announced today that filmmaker Steven Spielberg will accept the 2002 Human Rights Campaign National Equality Aw
MED TIME TECHNOLOGY INTRODUCES THE PILL TIMER Med Time Technology, Inc. s new invention, The Pill Timer, is the only medication monitoring and compliance device that s recommended by pharmacists and meets USP safety standards. This helps individuals who sometimes forget to take their medications. Medicine must be taken
HAMBURG, Germany and ABINGDON, England, Aug. 22 /PRNewswire-FirstCall/ -- Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a partner for integrated high-value-added drug discovery to the pharmaceutical and biotechnology industries, today announced that it granted a licence to Roche Diagnostics GmbH, the German affil
PLEASANTON, Calif., Aug. 22 /PRNewswire/ -- Roche Molecular Systems, Inc. (Roche) today announced the start of comprehensive clinical trials of its COBAS AmpliScreen(TM) HBV Test. The trials mark an important milestone because, for the first time in the U.S., Roche s PCR nucleic acid amplification technology (NAT) test
EMERYVILLE, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Chiron Corporation (Nasdaq: CHIR) today named Jack Goldstein, 55, as president of Chiron s Blood Testing division. Based in Emeryville, Dr. Goldstein will be responsible for the commercial operations of Chiron s blood testing business. He will also serve as a member
RANCHO SANTA MARGARITA, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Trinity Medical Group USA, Inc. (OTC Bulletin Board: TMGU) today publicly announced clinical results presented at a scientific conference on therapeutic and preventive HIV vaccines indicating that HIV-positive patients in Thailand taking highly ac
ORTHO BIOTECH TO DISTRIBUTE REBOUND FROM ANEMIA BROCHURE: Pro basketball star Alonzo Mourning and Ortho Biotech Products, L.P. are distributing a free brochure, Rebound from Anemia, to educate and encourage the millions at risk for anemia. For more information about the program, call 1-800-251-0627 or visit www.procrit
YONKERS, N.Y., Aug. 20 /PRNewswire-FirstCall/ -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that the results of a randomized, controlled and blinded clinical study of Product R therapy in patients with HIV/AIDS have been published in the July/August 2002 issue of HIV Clinical Trials. This
ROYAL OAK, Mich., Aug. 19 /PRNewswire/ -- On Sunday, August 11, 2002, Danielle Dipert, Dan Gilleran and Sara Johnson, team leaders for the Grosse Pointe North High School Walk Team, and approximately 40 other students and teachers gathered for a kick-off rally to begin building their team for AIDS Walk Detroit 2002. Th
NUTLEY, N.J., Aug. 19 /PRNewswire/ -- Roche announced today that the U.S. Food and Drug Administration ( FDA ) granted approval of its antiemetic, Kytril(R) Injection (granisetron hydrochloride) for both the prevention and treatment of post-operative nausea and vomiting (PONV). When used for prevention, Kytril is given
MELBOURNE, Australia , Aug. 19 /PRNewswire-FirstCall/ -- * Virax expands development program into third product area * Prestigious US organisation seeks Virax collaboration * Visit http://www.virax.com.au for more information Virax Holdings Limited (ASX: VHL) announced today that it has signed a development agreement w
-- Global Technology Expands as Company-held Patents Approach the 400 Mark -- Clinical Trial for HIV and Hepatitis C Set to Start in Spain PHILADELPHIA, Aug. 19 /PRNewswire-FirstCall/ -- Hemispherx Biopharma has received a Letter of Intent for a potential multimillion-dollar investment in the Company by the Royal Famil
GARDENA, Calif., Aug. 19 /PRNewswire/ -- Nissan North America, Inc., (NNA) today announced that the first 2003 Nissan 350Z(TM), VIN 0000001, will be available for bidding on eBay Motors. Nissan, in conjunction with the Entertainment Industry Foundation, will donate the winning bid amount to the Elizabeth Glaser Pediatr
NUTLEY, N.J. and DURHAM, N.C., Aug. 16 /PRNewswire/ -- Responding to patient need, Roche and Trimeris today announced that physician enrollment for the U.S. Early Access Program for Fuzeon(TM)* ( enfuvirtide ), formerly known as T-20, will open on Monday, August 19. This program, running parallel with other controlled
CARLSBAD, Calif., Aug. 15 /PRNewswire-FirstCall/ -- Indicating for the first time in a clinical trial that REMUNE(R) might give relief for HIV- infected patients from the adverse side-effects of antiretroviral therapies, The Immune Response Corporation (Nasdaq: IMNR) announced today results from an ongoing study by the
ALAMEDA, Calif., Aug. 14 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CALY) today announced that its Chairman Anthony Cataldo, CEO Nancy Katz, and CFO Richard Brounstein today affirmed the accuracy of Calypte s Form 10-Q for the period ending June 30, 2002 as filed with the Securities a
-- Gen-Probe distribution to the shareholders of Chugai expected on or about September 15, 2002; Company expects to begin trading on the Nasdaq National Market(R) under ticker symbol GPRO on September 16, 2002 SAN DIEGO, Aug. 14 /PRNewswire/ -- Gen-Probe Incorporated, an established leader in molecular diagnostics base
CHICAGO, Aug. 14 /PRNewswire/ -- Norzyme, Inc., developers of in-vitro diagnostic technology for therapeutic drug monitoring, today announced the National Institutes of Health (NIH) has further recognized the promise of its Levoprin-ZG(TM) product to aid in the disease management of HIV-AIDS patients with the award of
SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN), a biotechnology company focused on the development of pharmaceutical products using multiple, specific epitopes to activate the body s immune system, today announced that the U.S. Patent and Trademark Office recently issued the Company a patent
PRINCETON, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Data from a large observational cohort study published in the July/August issue of HIV Clinical Trials showed that anti-HIV combination treatment regimens containing SUSTIVA(R) ( efavirenz ) had a better virologic response than regimens containing
BALTIMORE, Aug. 9 /PRNewswire/ -- A group led by the Johns Hopkins University Center for Communication Programs (JHU/CCP) has been awarded $127 million by the U.S. government to implement a five-year global project designed to use strategic communication to fight infectious diseases such as HIV/AIDS, TB, and malaria; i
WASHINGTON, Aug. 8 /PRNewswire/ -- In response to new government inquiries into abuse and mismanagement in federal AIDS programs, Citizens Against Government Waste, the nation s largest taxpayer watchdog, today re-released its February 2002 report, AIDS Programs: An Epidemic of Waste. (See the report at http://www.cagw
SAN DIEGO, Aug. 8 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN), a biotechnology company focused on the development of pharmaceutical products using multiple, specific epitopes to activate the body s immune system, today announced its financial results for the second quarter ended June 30, 2002. Second quarter
WHAT: Una Noche de Esperanza (A Night of Hope), seventh-annual awards dinner and art auction to benefit AltaMed Health Service, a leading organization focusing on growing HIV/AIDS crisis in the Latino community. The concert-style event will also include celebrity appearances and entertainment. WHEN: Sunday, Aug
SOUTH SAN FRANCISCO, Calif., Aug. 8 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) announced today that the spread of drug-resistant HIV has accelerated rapidly over the last several years according to research using its technology and published in this week s issue of The New England Journal of Medicine. Dru
ALAMEDA, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CALY), the developer and marketer of the only two FDA-approved HIV-1 Antibody tests that can be used on urine samples announced today that it has received its first West African order. The order calls for delivery of t
LOS ANGELES, Aug. 7 /PRNewswire/ -- The devastating affect of HIV/AIDS on the Latino community will be spotlighted at AltaMed s seventh annual fundraiser, Una Noche de Esperanza (A Night of Hope) leadership awards dinner and art auction on Sunday, Aug. 11 at Hollywood s House of Blues. The event begins at 5:30 p.m. Pro
BRISBANE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- VaxGen , Inc. (Nasdaq: VXGN) today announced a net loss of $6.7 million, or 46 cents per share excluding non-cash charges, for the second quarter ended June 30, 2002, compared with a net loss of $5.9 million, or 42 cents per share excluding non-cash charges, in the sec
ELIZABETH CITY, N.C., Aug. 6 /PRNewswire-FirstCall/ -- ASGA, Inc. (OTC Bulletin Board: ASGA) announced today that its wholly owned subsidiary, ASGA Tour, Inc., has executed an Agreement to conduct an event November 1-3, 2002, with celebrities and golf professionals to benefit Population Services International s YouthAI
ATLANTA, Aug. 5 /PRNewswire/ -- Commissioner of Agriculture Tommy Irvin announced today that Georgia Department of Agriculture food scientists have found some contamination in a brand of fresh bay leaves pulled from a store sample. A sample of Melissa s Fresh Bay Leaves was found to be contaminated with Listeria monocy
DURHAM, N.C., Aug. 5 /PRNewswire-FirstCall/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) announced today that Daniel G. Welch has been appointed Chairman and CEO effective August 5, 2002. Mr. Welch succeeds Dr. David Barry, founder and former Chief Executive Officer, who passed away in January of this year. Mr. Wel
SOUTH SAN FRANCISCO, Calif., Aug. 5 /PRNewswire/ -- Sunesis Pharmaceuticals, Inc. today announced the discovery of a potent, small molecule inhibitor of Interleukin-2 ( IL-2 ), providing the most advanced proof of principle to date of the Company s Tethering technology. This approach reliably generates small molecule
CHICAGO, Aug. 5 /PRNewswire/ -- New, antiinfective substances that can be developed as gels, creams, foams, films, even impregnated sponges and suppositories may prove to be a ground-breaking approach to preventing the spread of HIV, the virus that causes AIDS, according to an international authority and clinical pharm
ATLANTA, Aug. 2 /PRNewswire/ -- Georgia Department of Agriculture food scientists report finding contamination of Reser s White Meat Chicken Salad pulled from a grocery store sample. Commissioner Tommy Irvin urges anyone who has it at home to return it to where they bought it. Georgia s test showing the presence of Lis
LOS ANGELES, Aug. 2 /PRNewswire/ -- California s representatives in Congress today joined across party lines to ask House of Representatives leadership to end waiting lists for AIDS drugs by increasing funds for treatment. With over 1,200 uninsured Americans on waiting lists for life- saving medications, we re proud to
SOUTH SAN FRANCISCO, Calif., Aug. 1 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today reported financial results for the second quarter ended June 30, 2002. The Company reported revenue of $6.7 million for the second quarter, up 40 percent over revenue of $4.8 million for the same period in 2001. I am plea
INDIANAPOLIS, July 31 /PRNewswire/ -- Today Roche Diagnostics announced that on July 26, 2002, it received marketing approval from the U.S. Food and Drug Administration ( FDA ) for the Roche AMPLICOR HIV-1 MONITOR(R) Test, version 1.5. This test is a highly sensitive laboratory test to measure levels of HIV circulating
WASHINGTON, July 31 /PRNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation announced today that the United States Agency for International Development (USAID) has awarded a grant of up to $100 million over five years to the Foundation s international Call to Action Project, which is taking immediate action to p
DURHAM, N.C., July 30, 2002 /PRNewswire-FirstCall/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) today announced positive findings from FTC-301, an ongoing pivotal Phase III trial of Coviracil (emtricitabine), its nucleoside reverse transcriptase inhibitor for the treatment of HIV disease. With these results, the Co
DURHAM, N.C., July 30, 2002 /PRNewswire-FirstCall/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) today announced that it has reacquired from Abbott Laboratories (NYSE: ABT) full product rights, including rights to all profits, for four drug candidates in clinical development, including Coviracil(R) (emtricitabine) f
LONG BRANCH, N.J., July 30 /PRNewswire/ -- The first of four meetings featured at the World Antibody Summit 2002, Antibody Discovery & Clinical Drug Development will feature the presentation of exciting clinical data in a variety of therapeutic areas on September 16, announces Strategic Research Institute. Alexion,
DUBLIN, Calif., July 25 /PRNewswire-FirstCall/ -- SuperGen, Inc. (Nasdaq: SUPG) announced today that its oral anticancer cancer compound Orathecin(TM) has received orphan-drug designation from the Food and Drug Administration ( FDA ) for the treatment of pediatric patients infected with human immunodeficiency virus (HI
Estimates at the recent International AIDS Conference in Barcelona indicate that over 40 million people worldwide are infected with HIV with almost one million of them in the U.S. alone Dr. Fernandez-Cruz and Dr. Moss are presenting data at the 2002 Federation of American Societies for Experimental Biology s (FASEB) Su
SOUTH SAN FRANCISCO, Calif., July 24 /PRNewswire/ -- Sunesis Pharmaceuticals, Inc. announced today that the company has been granted a $600,000, two-year Phase I Small Business Innovative Research grant from the National Institute of Allergy and Infectious Diseases. The grant was awarded to Sunesis to develop inhibitor
LONG BRANCH, N.J., July 24 /PRNewswire/ -- The first of four meetings featured at the World Antibody Summit 2002, Antibody Discovery & Clinical Development will feature the presentation of exciting clinical data in a variety of therapeutic areas on September 16, announces Strategic Research Institute. Alexion, Prot
WASHINGTON, July 22 /PRNewswire/ -- The following is a statement of Werner Fornos, President of the Population Institute* on the refusal to release the Congressional Appropriation for the United Nations Population Fund: By withholding the $34 million Congress appropriated for United Nations family planning and reproduc
WINSTON-SALEM, N.C., July 22 /PRNewswire/ -- Kucera Pharmaceutical Co., a Winston-Salem-based biotechnology spinoff of Wake Forest University s School of Medicine, has retained Fyock & Associates for media and public relations services. We have enjoyed working closely with Fyock & Associates through its media r
Johannesburg - For more than a decade, Metropolitan has been the leader in providing South African business with accurate and cutting-edge information on HIV and AIDS. In 1999, Metropolitan launched its www.redribbon.co.za website, which quickly gained a reputation as the leading HIV/AIDS on-line information resource c
WASHINGTON, July 19 /PRNewswire/ -- The pro-life cause registered a significant victory late Thursday when, on a unanimous consent vote, the Senate unexpectedly passed the Born-Alive Infants Protection Act. In other news, a personnel shuffle at the White House over its approach to HIV/AIDS policy, has pro-family conser
LEIDEN, Netherlands , July 19 /PRNewswire-FirstCall/ -- Dutch antibody and vaccine company Crucell N.V. (Nasdaq: CRXL; Euronext) today announced that it has appointed Dr. Jaap Goudsmit to the Executive Committee as Chief Medical Officer and Executive Vice President Vaccine R&D. Dr. Goudsmit will be responsible for
NEW YORK, July 18 /PRNewswire/ -- The United Nations Children s Fund today urged the world community to help save the lives of more than 6 million children who are at immediate risk of death in southern Africa due to a crippling combination of natural and man-made crises. Speaking in support of an emergency UN appeal f
NEW HAVEN, Conn., July 17 /PRNewswire/ -- Achillion Pharmaceuticals today announced receipt of regulatory clearance and the commencement of a Phase 2 clinical study with Company s lead product candidate, ACH-126,443 (Beta-L-Fd4C), in patients with HIV/AIDS. The study is being conducted under Achillion s second Investig
ALBUQUERQUE, N.M., July 15 /PRNewswire-FirstCall/ -- Cell Robotics International, Inc. (OTC Bulletin Board: CRII.OB) producer of the laser capillary blood-sampling device announces that it has retained H. C. Wainwright & Co., Inc. to assist in raising near-term operating and expansion capital and to provide other f
NUTLEY, N.J., July 15 /PRNewswire/ -- The U.S. Food and Drug Administration ( FDA ) has granted a six-month Priority Review Status to the Biologics License Application (BLA) and New Drug Application (NDA) for Roche s combination therapy of PEGASYS(R) (peginterferon alfa-2a) and Roche ribavirin tablets, for the treatmen
AMARILLO, Texas, July 15 /PRNewswire-FirstCall/ -- Amarillo Biosciences, Inc. (OTC Bulletin Board: AMAR) announces the Company has signed a licensing agreement with African Health Solutions, LLC, Greenville, Delaware providing the rights to oral low-dose interferon alpha for the treatment of hepatitis B patients in Afr
A scientist at King s College London has discovered a unique gene in humans that acts as a defence against attack from human immunodeficiency virus, HIV, the virus that causes AIDS. The gene, CEM15, represents a new type of natural resistance to viral activity that could be exploited to produce new treatments for HIV o
LOS ANGELES -- On Thursday, July 18th, the stars will be shining bright in Los Angeles as they turn out to support Artists Against AIDS Worldwide (AAAW). Sponsored by MTV and VH1 and hosted by the much-anticipated new restaurant, The Spanish Kitchen, the event will celebrate Sexual Healing in the artistic community and
BARCELONA, Spain -- Data presented today at the XIV International AIDS Conference demonstrated that patients with HIV (human immunodeficiency virus) experienced significant reductions in blood levels of total cholesterol, low-density lipoprotein (LDL) or bad cholesterol and triglycerides when switched from the protease
BARCELONA, Spain -- Data presented today at the XIV International AIDS Conference show that the investigational one- capsule, once-daily extended release formulation of Bristol-Myers Squibb s (NYSE: BMY) nucleoside reverse transcriptase inhibitor (NRTI) ZERIT(R) ( stavudine ) ha
BARCELONA, Spain -- XIV International AIDS Conference -- Two years after the widespread optimism of the International AIDS Conference in Durban, Barcelona 2002 is a splash of cold water and a reality check on how the world is doing in the fight against AIDS, said Seth F. Berkley, MD, President and CEO of the Internatio
BARCELONA, Spain -- Data presented this week at the XIV International AIDS Conference show that a greater proportion of patients on highly active antiretroviral therapy (HAART) containing SUSTIVA(R)( efavirenz ), Bristol-Myers Squibb s (NYSE: BMY) once-daily non- nucleoside reverse transcriptase inhibitor (NNRTI), achi
BARCELONA, Spain -- Women leaders from around the world will spoke Wednesday evening at the International AIDS Conference on expanding access to effective solutions for women and girls suffering from AIDS. Women United Against AIDS, sponsored by the International AIDS Trust and UNAIDS , i
Barcelona, Spain -- Urging young people to abstain from sex in Zambia may not appear to make sense in a country where 75 percent are sexually active, but an AIDS prevention program sponsored by the U.S. Agency for International Development (USAID) shows young Zambians crave support for their decision to abstain and pre
BARCELONA, Spain -- Before a global audience at the XIV International AIDS Conference, The Immune Response Corporation (NASDAQ: IMNR) announced today that data from a Phase II clinical trial (STIR - 2102) of REMUNE(R) was presented by Dr. Eduardo Fernandez-Cruz, head of Department of Clinical Immunology at the Universi
BARCELONA, Spain -- Whereas official estimates are between 26.4 million and 44 million AIDS orphans by 2010, AFXB projects the breathtaking figure of 100 million AIDS affected children. Based on his scientific expertise, on his own research in Uganda and India and on the experien
PRINCETON, N.J. -- A once-daily drug regimen comprised of three leading anti-HIV medications may allow HIV patients, who previously followed complicated, multi-dose drug regimens, to create a once-daily combination therapy to reduce the frequency of dosing of their HIV treatment. The combination of the once-daily formu
BARCELONA, Spain -- AIDS Healthcare Foundation (AHF), the largest non-government provider of AIDS medical services in the Unites States, today led a peaceful demonstration at the International AIDS Conference in Barcelona that shut down British-owned GlaxoSmithKline , protesting the pharmaceutical giant s AIDS drug
BARCELONA, Spain -- The International Association of Physicians in AIDS Care (IAPAC) today announced two initiatives to significantly enhance healthcare infrastructure in developing countries struggling to fight the AIDS pandemic. The initiatives are an effort to improve the quality of care for people with HIV/AIDS and
BARCELONA, Spain -- The Immune Response Corporation (NASDAQ: IMNR) announced today that the Adult AIDS Clinical Trials Group of the National Institutes of Health presented new data at the XIV International AIDS Conference from a clinical trial designed to ascertain if the non-specific cytokine, Interleuken two (
BARCELONA, Spain -- More than 30,000 patients with advanced HIV infections in 15 African and Caribbean countries could be put into an innovative, cost-effective treatment program developed by AIDS Empowerment and Treatment International, according to data presented at the International AIDS Meeting here. The networ
BARCELONA, Spain -- A new public service advertising (PSA) campaign aimed at communicating to Americans the breadth of the AIDS pandemic and its effects on the lives of children premiered today at the AIDS 2002 Barcelona XIV International AIDS Conference. The campaign, entitled Apathy is Lethal, highlights the plight o
BARCELONA, Spain -- Clinical study results presented today indicate that HIV patients who switched their twice-daily protease inhibitor regimen of boosted saquinavir, by increasing the dose of saquinavir and minimizing the booster dose of ritonavir , were able to maintain viral suppression below 400 cop
BARCELONA, Spain -- Data from the MaxCmin1 trial, the first large, randomized study to compare boosted HIV protease inhibitor regimens, showed that boosted saquinavir (saquinavir 1000 mg with ritonavir 100 mg) reduced HIV to undetectable levels (
BARCELONA, Spain -- The National Minority AIDS Council delegation to the XIV International Conference on AIDS called on the Bush Administration to rethink its global AIDS funding policy announced recently. The group s call came in response to an address Tuesday to the 15,000 delegates attending the conference by U.S. S
BARCELONA, Spain , July 9 /PRNewswire/ -- Helene Gayle, the Bill & Melinda Gates Foundation s program director for HIV/AIDS and TB, today reaffirmed the foundation s commitment to HIV prevention. Dr. Gayle delivered the opening plenary on prevention at the XIV International AIDS Conference in Barcelona, where she i
What: PEACEFUL PROTEST & PRESS CONFERENCE to KICK OFF Divest GSK CAMPAIGN When: Wednesday, July 10th 12:00noon-2pm Where: in front of GSK s Booth International AIDS Conference, Fira de Barcelona Conference Center Building #2 (near the media center) Contact: Ged Kenslea +1.323.791.5526 Who: AIDS ADVOCATES
BARCELONA, Spain -- HIV/AIDS has always been an epidemic of young people, but new projections indicate that if trends persist, the current impact on youth is only the tip of the iceberg, according to a report released today by the Kaiser Family Foundation. Analysis of new U.S. Census Bureau data by the Foundation proje
BARCELONA, Spain -- XIV International AIDS Conference, -- The International AIDS Vaccine Initiative (IAVI) outlined a new, intensified research and development agenda that the organization and its worldwide partners are undertaking to expedite the development of vaccines to prevent HIV/AIDS, focusing on those tailored
BARCELONA, Spain -- XIV International AIDS Conference -- A new consortium of leading AIDS laboratories, working with the US government s Vaccine Research Center, and brought together by the International AIDS Vaccine Initiative (IAVI), hopes to speed the discovery of a vaccine to prevent HIV/AIDS through collaboration
BARCELONA, Spain -- ViroLogic, Inc. (NASDAQ: VLGC) announced today that 11 studies using its proprietary PhenoSense(TM) drug resistance testing technology will be presented here this week at the 14th International AIDS Conference. These studies demonstrate the utility of combined phenotypic-genotypic resistance testing
BARCELONA, Spain -- Roche and Trimeris, Inc. (NASDAQ: TRMS) today announced that data collected from a survey of patients in two large, internationally conducted Phase III trials suggest that subcutaneous delivery of T-20 was well-accepted by a majority of patients after the first eight weeks of treatment. These data,
BARCELONA, Spain -- Roche today announced encouraging results of four new studies examining double boosting -- an investigational treatment strategy which combines a twice-daily regimen of saquinavir (1000 mg) with Kaletra (TM) ( lopinavir 400 mg/ritonavir 100 mg) -- in
ROCKLAND, Mass. and GENEVA -- Serono S.A. (virt-x: SEO and NYSE: SRA) announced positive results of two major clinical trials of Serostim(R) [somatropin (rDNA origin) for injection] for the treatment of AIDS-related metabolic complications at the XIV International AIDS Conference in Barcelona, Spain . Results
BARCELONA -- Pfizer Inc Chairman and CEO Hank McKinnell today announced the establishment of the Pfizer Health Fellows Program to provide needed human resources to combat HIV/AIDS in Africa and other hard hit areas. The new program follows other company efforts to increase donations of free medicines and other forms of
LOS ANGELES -- On July 2, 2002, the California Court of Appeals let stand a decision of the state s trial courts requiring PacifiCare of California ( PacifiCare ) to turn over to AIDS Healthcare Foundation (AHF ) records and documents pertaining to PacifiCare members with HIV/AIDS. The Court implicitly agreed that thes
WOODRIDGE, Ill. -- Sarawak MediChem Pharmaceuticals, Inc. announced today that it has begun screening volunteers for a 48 subject, clinical trial of Calanolide A in combination therapy for HIV. This clinical trial will evaluate the therapy s safety and pharmacokinetics. Upon conclusion of this study, Sarawak MediChem P
BARCELONA, Spain -- Seth Berkley, MD, president and chief executive officer of the International AIDS Vaccine Initiative (IAVI), issued the following statement upon learning of Thailand s intention to move forward with the world s largest preventive HIV vaccine trial: From the beginning of this pandemic, Thailand has s
BARCELONA, Spain -- The Bill & Melinda Gates Foundation today announced the premiere of Pandemic: Facing AIDS, the moving and insightful new film by Rory Kennedy and Moxie Firecracker Films. Pandemic, which will premiere at the XIV International AIDS Conference in Barcelona, is a feature-length documentary that tak
VANCOUVER -- AnorMED Inc. announced today that it has identified a new lead drug candidate for HIV called AMD-070. Dr. Gary J. Bridger, Ph.D, AnorMED s Vice President, Research and Chief Scientific Officer, an invited speaker in the New Drugs, New Targets Symposium, presented data today on a new class of HIV Entry Inhi
GAITHERSBURG, Md. -- Panacos Pharmaceuticals, Inc. today made its first public presentation on the Company s innovative HIV drug candidate, PA-457, at the XIV International AIDS Conference in Barcelona, Spain . PA-457 is the first in a new class of drug candidates known as Budding Inhibitors that offer a completely nov
BARCELONA, Spain -- The Immune Response Corporation (NASDAQ: IMNR) announced today the presentation of data at the XIV International AIDS Conference which suggest that REMUNE(R) induced helper T-cell immune responses aimed specifically at HIV in chronically infected HIV-positive individuals taking HAART (Highly Active
BARCELONA, Spain -- ViroLogic, Inc. (NASDAQ: VLGC) announced today that research published in this week s issue of the Journal of the American Medical Association (JAMA) and announced here at the 14th Annual International AIDS Conference indicate that resistance testing should play a greater role in guiding treatment f
BARCELONA, Spain -- Data from two large, internationally conducted Phase III trials indicate that combination therapy with T-20 reduced HIV to undetectable levels in the blood in at least twice the percentage of patients and provided an improved immune response at 24 weeks, as compared to those who took combination the
BARCELONA, Spain -- Data presented at the 14th International AIDS Conference in Barcelona shows the three-year efficacy and tolerability of a Kaletra-based regimen in 100 patients new to antiretroviral therapy (naive). This promising data demonstrated that a drug regimen including Kaletra provided viral suppression (as
Barcelona, Spain - Today world renowned HIV experts unveiled positive results from two large scale international studies with T-20, the furthest in clinical development of a new class of investigational antiretroviral drugs called fusion inhibitors . Phase III results presented for the first time, show that levels of H
BARCELONA, Spain -- Data presented at the 14th International AIDS Conference in Barcelona shows the three-year efficacy and tolerability of a Kaletra-based regimen in 100 patients new to antiretroviral therapy (naive). This promising data demonstrated that a drug regimen including Kaletra provided viral suppression (as
BARCELONA, Spain -- Thousands of AIDS activists today took to the streets in Barcelona at the International AIDS Conference March for Life demanding AIDS treatment now for the world s HIV-infected, ninety-eight percent of whom do not receive life-saving treatment. You represent the voice of millions seeking help just t
WASHINGTON -- A study of HIV-infected patients in Baltimore, Maryland, revealed that individuals seropositive for hepatitis C had similar clinical outcome measures when treated with antiretroviral drug regimens compared to seronegative patients. These findings will be presented at a July 6 press conference at the XIV I
SEVILLE, Spain -- Study findings demonstrate that a tipranavir-based HIV/AIDS treatment regimen produced a significant reduction in HIV-1 levels in patients who previously had received treatment with multiple protease inhibitor-based (PI) regimens. Data from this trial and an additional in vitro study further character
Seville, Spain - A radical new initiative in HIV management was launched today at the XI International HIV Drug Resistance Workshop. The International HIV Resistance Response Database Initiative, or RDI, will combine data from thousands of HIV patients around the world into a freely accessible database that could enhan
LEIDEN, The Netherlands -- Dutch antibody and vaccine company Crucell N.V. (Nasdaq, Euronext: CRXL) and Genexine Co. Ltd., a Korean drug development company, today announced that they have entered into a licensing agreement wherein Crucell s PER.C6(TM) cell line will be used by Genexine for the research, development an
NUTLEY, N.J. and DURHAM, N.C. -- Roche and Trimeris, Inc. (Nasdaq: TRMS) today announced final results of a Phase I/II study demonstrating that T-1249, a second-generation fusion inhibitor candidate, was well-tolerated and exhibited antiviral activity in HIV patients. Unlike existing anti-HIV drugs that work inside the
TORONTO -- Visible Genetics Inc. (Nasdaq: VGIN) (VGI) scientists have identified a number of new mutations in the HIV genetic code that may be making the virus resistant to T-20, the first of a new class of experimental drugs called fusion inhibitors. The results, which were presented today at the XI International Work
BOTHELL, Wash. -- Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that the U.S. Food and Drug Administration ( FDA ) has approved a labeling supplement to the Nascobal(R) NDA that states that Nascobal can be used in patients with HIV, AIDS, multiple sclerosis, and Crohn s disease, conditions which ca
BARCELONA, Spain -- Organizers of the July 7 March for Life, representing 500 AIDS organizations across the globe, are protesting the favoritism being shown by the International AIDS Conference to the big drug companies, the only principal sponsors of the conference. Companies pay $1 million to hawk their wares to 14,0
SOUTH SAN FRANCISCO, Calif. -- ViroLogic, Inc. (Nasdaq: VLGC) announced today that HIV replication capacity (sometimes called viral fitness ) is an important indicator of clinical outcomes at multiple stages of HIV infection, according to several new studies to be presented later this week at the 11th International HIV
AIDS Thrift Store Premieres Wednesday, July 3rd - Via 10 AM Ribbon-cutting: Hollywood Lends Hand With Generous Donations Including Set Pieces From Fox-TV s The X-Files, Props From Warner Bros. and a Pool Table From Academy Award-Winning Director Ron Howard WHAT: Grand Opening -- Out of the Closet thrift store WHEN:
LOS ANGELES -- The largest AIDS organization in the United States today files a federal lawsuit charging British-owned GlaxoSmithKline with anti-trust violations that could break the manufacturer s monopolistic hold on key AIDS drugs in the United States. AIDS Healthcare Foundation (AHF) -- represented by the law f
BALTIMORE -- A 23 year old Namibian leading efforts to help families of those in his community stricken by HIV/AIDS, an 18 year old radio journalist in Vietnam whose stories on environmental and social issues have reached over 30 million people, and a young Peruvian working to provide poor children in the Amazon rainfo
RANCHO SANTA MARGARITA, Calif., June 28 /PRNewswire-FirstCall/ -- Trinity Medical Group USA, Inc. (OTC Bulletin Board: TMGU) announces that it has amended its REMUNE License and Collaboration contract with The Immune Response Corporation (Nasdaq: IMNR). The amended contract provides for an additional $50.00 per unit to
PHILADELPHIA, June 27 /PRNewswire-FirstCall/ -- It happens in the blink of an eye...a medical worker handling a just-used syringe or involved with an injection for a patient with a contagious disease gets nicked in the process. Ordinarily, there is no effect beyond the momentary sting of the pinprick. But those seeming
CHICAGO, June 27 /PRNewswire/ -- The International Association of Physicians in AIDS Care (IAPAC) is concerned by recent news indicating that many developing world physicians, allied health professionals, and advocates seeking to participate in the upcoming XIV International AIDS Conference in Barcelona,
NUTLEY, N.J., and DURHAM, N.C., June 26 /PRNewswire-FirstCall/ -- The XIV International AIDS Conference (IAC), the world s largest HIV/AIDS meeting, to be held in Barcelona, Spain , July 7-12, will focus in part on classes of antiretrovirals that attack HIV in a novel way. One developmental class, fusion inhibitors, is
LONG BRANCH, N.J., June 25 /PRNewswire/ -- The first of four meetings featured at the World Antibody Summit 2002, Antibody Discovery & Clinical Development will feature the presentation of exciting clinical data in a variety of therapeutic areas on September 16, announces Strategic Research Institute. Alexion, Prot
WASHINGTON, June 25 /PRNewswire/ -- The following is a transcript of remarks by Gary Edson: THE WHITE HOUSE Office of the Press Secretary 10:25 A.M. EDT MR. FLEISCHER: Let me turn you over to Mr. Gary Edson. Are you going to do this on the record? MR. EDSON: Any way you want. MR. FLEISCHER: Let s do this on the record,
LOS ANGELES, June 25 /PRNewswire/ -- AIDS Healthcare Foundation (AHF) today praised a recent decision by President Bush s Advisory Council on HIV/AIDS (PACHA) urging federal authorities to make rapid HIV testing widely available. This technology will revolutionize HIV testing in the US, said Clint Trout, spokesman for
NEWTON UPPER FALLS, Mass., June 24 /PRNewswire/ -- Predictive Pharmacogenomics: Revolutionizing Health Care, a new Life Science Report published by Cambridge Healthtech Institute (CHI) examines developing technologies designed to use an individual s genomic profile to predict response to certain drugs, enabling better
VICTORIA, BC, Canada and SAN DIEGO, CA, USA, June 24 /PRNewswire- FirstCall/ - Stressgen Biotechnologies Corporation (TSX:SSB) and Roche announced today that they have entered into a Collaboration Agreement for the co-development and global commercialization of Stressgen s innovative proprietary heat shock protein (Hsp
NEW HAVEN, Conn., June 24 /PRNewswire/ -- Achillion Pharmaceuticals, today announced that John C. Pottage, Jr., MD has joined the Company as Senior Director, Drug Development. In this position, Dr. Pottage will play a significant role in the pre-clinical and clinical development of Achillion s product candidates design
WASHINGTON, June 21 /PRNewswire/ -- When most metro area youth beat ya feet, their sole intention is to show mastery of the latest go-go dance craze. However, when they beat ya feet at BET s Rap-it-Up Unity in the Community Day, they ll be helping to stomp the spread of HIV and AIDS in the metro area. On Thursday, June
LOS ANGELES, June 21 /PRNewswire/ -- 500 AIDS organizations are endorsing the March for Life, which immediately precedes the July 7 opening ceremonies of the upcoming International AIDS Conference in Barcelona, Spain , according to AIDS Therapeutic Treatment Now (ATTN), a global coalition seeking treatment for at least
WASHINGTON, June 20 /PRNewswire/ -- THE PRESIDENT: I m so honored to be with you all to pay tribute to an exceptional man and to further a great cause. Leon Sullivan understood an important principle: If we want to live in a world that is free, we must work for a world that is just. (Applause.) The free people of Ameri
BALTIMORE, June 20 /PRNewswire/ -- Leaders of Baltimore s African American community met today with the National Black Leadership Commission on AIDS (BLCA) to develop an action plan to fight HIV/AIDS in Baltimore. Plans the leaders committed to: -- Declare Sunday, Sept. 29, 2002, as HIV/AIDS Awareness Day to encourage
What: PRESS CONFERENCE Unveiling STOP THE SORES Syphilis Awareness Social Marketing Campaign Who: Sybil Allen, MD, AHF Regional Medical Director, Southern California Celena Holloway, RN, Nurse Manager, AHF Westside Healthcare Center Terri Ford, AHF Director of Prevention Cesar Portillo, AHF Chief of Public Af
EMERYVILLE, Calif. and RARITAN, N.J., June 20 /PRNewswire/ -- Chiron Corporation (Nasdaq: CHIR) and Ortho-Clinical Diagnostics, a Johnson & Johnson company, announced today their joint sponsorship of the PBS documentary Red Gold: The Epic Story of Blood. This four-part mini-series will premier on two consecutive Su
HOLLYWOOD, June 20 /PRNewswire/ -- When the African-American celebrity A-List walks down the red carpet of the Kodak Theatre before the 2ND ANNUAL BET AWARDS on Tuesday, June 25, there will be one face among them far less recognized, but equally as worthy of recognition for his outstanding work. Instead of contributing
PHILADELPHIA, June 20 /PRNewswire-FirstCall/ -- GlaxoSmithKline (GSK) (NYSE: GSK) today announced that it has implemented a two-year freeze in the U.S. list price(1) of the company s entire portfolio of anti-HIV products through January 2004. GSK will continue to provide its HIV drugs free of charge(2) through its Pati
ABBOTT PARK, Ill., June 19 /PRNewswire/ -- Abbott Laboratories announced today a donation of its HIV rapid test, Determine(TM) HIV, to programs aimed at preventing mother-to-child transmission (PMTCT) of HIV in the 68 African and Least Developed Countries (LDCs), as defined by the United Nations. The donation is the f
WASHINGTON, June 19 /PRNewswire/ -- The following are remarks by the President in announcement of International Mother and Child HIV Prevention Initiative: The Rose Garden 9:04 A.M. EDT THE PRESIDENT: Good morning. The global devastation of HIV/AIDS staggers the imagination and shocks the conscience. The disease has al
SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) announced today that the Company has signed an expanded agreement with Pfizer Inc (NYSE: PFE) to use ViroLogic s novel HIV resistance testing technology for Pfizer s HIV drug discovery and development programs. The new agreeme
WHAT: VaxGen (Nasdaq: VXGN) will hold a conference call and webcast Wednesday, June 19, to review its AIDS vaccine technology prior to the XIV International AIDS Conference in July. The presentation will give AIDS reporters and conference attendees an in-depth understanding of VaxGen s Phase III clinical tri
SOUTH SAN FRANCISCO, Calif., June 17 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) announced the presentation of preclinical results demonstrating that one of its insulin receptor activator small molecule drug candidates reversed insulin resistance induced by a human immunodeficiency virus (HIV) protease inhibit
TORONTO, June 17 /PRNewswire-FirstCall/ -- Visible Genetics Inc. (Nasdaq: VGIN) (VGI) is pleased to announce that it has launched a new internet resource at http://www.trugene.com that provides a comprehensive range of information on the company s TRUGENE genotyping products, services and activities. Today also sees th
ABBOTT PARK, Ill., and BETHLEHAM, Pa., June 17 /PRNewswire-FirstCall/ -- Abbott Laboratories (NYSE: ABT) and OraSure Technologies (Nasdaq: OSUR) today announced agreements for the co-exclusive distribution of OraSure Technologies OraQuick(R) rapid test for the detection of antibodies to the Human Immunodeficiency Virus
MONTREAL, June 13 /PRNewswire/ - Pharmacor Inc. has been issued U.S. patent application no. 09/526,209, relating to its antiretroviral program. The small- molecule compounds described in the patent, entitled Amino acid derivatives as HIV aspartyl protease inhibitors , demonstrate inhibitory activity against HIV protea
SAN DIEGO, June 13 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN), a biotechnology company focused on the development of pharmaceutical products using multiple, specific epitopes to activate the body s immune system, today announced that it has received clearance from the U.S. Food and Drug Administration to st
YONKERS, N.Y., June 12 /PRNewswire-FirstCall/ -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that its immunomodulator-type drug, Product R, has been approved by the supreme medical ethics committee (Helsinki Committee) of the Ministry of Health in Israel for a Phase I clinical trial. The
RESEARCH TRIANGLE PARK, N.C., June 11 /PRNewswire/ -- A recent four-city survey shows only one-fourth of men (26%) who say they get tested for sexually transmitted diseases (STDs) are getting tested for genital herpes , despite widespread knowledge among the survey participants that genital herpes is a highly contagiou
CARLSBAD, Calif., June 11 /PRNewswire-FirstCall/ -- Following the recent announcement suggesting increased HIV-specific immunity in primates through use of a new HIV combination vaccine, The Immune Response Corporation (Nasdaq: IMNR) today announced results of a study published in the journal Vaccine (20, 2002, 2684-92
DURHAM, N.C., June 10 /PRNewswire-FirstCall/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) today announced the final settlement among Emory University (Emory), GlaxoSmithKline and Shire Pharmaceuticals Group plc (Shire) of longstanding patent disputes involving lamivudine and Triangle s drug candidate Coviracil (emt
ARDEN HILLS, Minn., June 7 /PRNewswire/ -- Land O Lakes, Inc. added its support to an amendment introduced yesterday by U.S. Sen. Paul Wellstone (D-MN) and amended by U.S. Sen. Herb Kohl (D-WI), that would provide 100,000 metric tons of nonfat dry milk to help international relief efforts in the fight to combat HIV/AID
BRISBANE, Calif., June 7 /PRNewswire-FirstCall/ -- In response to inquiries from shareholders, VaxGen , Inc. (Nasdaq: VXGN) is making public a letter from company president Donald P. Francis, M.D., D.Sc., regarding an article published in this month s edition of Scientific American about VaxGen s AIDS vaccine candidate
BOSTON (Thursday, June 6, 2002) -- Although highly active antiretroviral therapies have greatly prolonged the lifespan of patients with AIDS, this condition remains a lethal disorder and the adverse effects of chemotherapy are often disabling. According to researchers at the American Society of Gene Therapy Annual Meet
LOS ANGELES, June 6 /PRNewswire/ -- Los Angeles-based AIDS Healthcare Foundation (AHF), the nation s largest HIV/AIDS medical care provider, will welcome Lakers basketball legend Earvin Magic Johnson on Wednesday, June 12 from 11 a.m. - 2 p.m., for the official dedication of the West Adams clinic that bears his name.
YONKERS, N.Y., June 6 /PRNewswire-FirstCall/ -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that its antiviral immunomodulator, Product R, was approved by the Israeli Ministry of Health for Phase I/II clinical trials in patients who have failed highly active anti-retroviral therapy (HAART)
NEW YORK, June 4 /PRNewswire/ -- As the games continue, and USA takes on Portugal tomorrow in Korea, UNICEF reminds the world about the positive benefits of sport in a child s life. Last year, FIFA and UNICEF forged a global alliance that promises far-reaching benefits for children; the 2002 World Cup is the partnershi
WASHINGTON, June 3 /PRNewswire/ -- John Lasee from Sturgeon Bay, Wis., joined a Land O Lakes delegation of dairy producer-members who spent three days in Washington D.C. last week. With the Farm Security and Rural Investment Act of 2002 now officially law, the group visited Capitol Hill to thank legislators for their s
WORCESTER, Mass., June 3 /PRNewswire/ -- Antigen Express, Inc. (AgExp) today announced that the US Patent and Trademark Office has granted a Notice of Allowance of a patent concerning its Ii-Key MHC Class II Platform Technology. Additionally, AgExp has received a $301,000 Phase I Small Business Innovative Research (SBI
SOUTH SAN FRANCISCO, Calif., June 3 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced the launch of the first-ever commercial laboratory test to evaluate the replication capacity (or viral fitness ) of HIV. ViroLogic s new Replication Capacity (RC) assay measures the ability of a patient s virus
LOS ANGELES, May 31 /PRNewswire/ -- AIDS Healthcare Foundation today called the anticipated merger of British pharmaceutical giant Glaxo Smithkline with Bristol Myers Squibb a certain disaster for people with AIDS throughout the world and called on American and European authorities to block the marriage. In contrast to
LOS ANGELES, and BARCELONA, Spain , May 31 /PRNewswire/ -- Los Angeles-based AIDS Healthcare Foundation (AHF), the largest provider of specialized HIV/AIDS medical care in the United States and the operator of two free AIDS treatment clinics in Africa ( South Africa &
CARLSBAD, Calif., May 30 /PRNewswire-FirstCall/ -- Citing an important step in ongoing research in the ability to trigger immune responses specific to human immunodeficiency virus (HIV), The Immune Response Corporation (Nasdaq: IMNR) announced today preliminary results from a non-human primate study in which CD4+ and C
CAMBRIDGE, Mass., May 29 /PRNewswire/ -- Novirio Pharmaceuticals Limited, a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced that the company has changed its name to Idenix Pharmaceuticals, Inc. The new name, Iden
DETROIT, May 28 /PRNewswire/ -- The Scott Building opens its doors Wednesday, May 29, 2002, at 9:30 a.m. with a ribbon-cutting ceremony. The facility expands Cass Community Social Services legacy of serving Detroit s homeless, mentally ill and chemically dependent. With its opening, the Scott Center becomes Michigan s
GENEVA, Switzerland and ROCKLAND, Mass., May 28 /PRNewswire/ -- Serono S.A. today announced the outcome of three randomized, double-blind, placebo-controlled clinical trials. Positive results of Serostim(R) in HARS A study of Serostim(R) [somatropin (rDNA origin) for injection] in 228 patients with HIV-Associated Adipo
The following is a joint statement by President George W. Bush and President Vladimir V. Putin on U.S.-Russian People-to-People Contacts: In keeping with the spirit of cooperation between our two countries, we affirm the importance of strengthening contacts between our societies and citizens. We are confident that dire
WASHINGTON, May 24 /PRNewswire/ -- Members of the Haitian health community met today with international HIV/AIDS experts to discuss the current status of the HIV/AIDS pandemic in Haiti. The group set out to identify solutions to a socio-economic problem that has reached crisis proportions in recent years. The panel was
EDMONTON, May 23 /PRNewswire-FirstCall/ - Mr. Warren Jackson, President and CEO of Altachem Pharma Ltd., is pleased to announce that the proposed Beijing Erdos Altachem Pharma Ltd. joint venture to be located in Beijing, China between Altachem Pharma Ltd. and Erdos Cashmere Corporation is in the process of regulatory a
HONG KONG, May 23 /PRNewswire/ -- Investors got a call to action from former US President Bill Clinton and rock-star-activist Bono. The two men were guest speakers at the 9th CLSA Investors Forum in Hong Kong , the world s largest gathering of investors in emerging markets. Clinton appealed to the 1,200 institution
BRUSSELS, Belgium , May 23 /PRNewswire/ -- Euroscreen s.a. has completed a license agreement with Pfizer Inc. of New York for access to Euroscreen s CCR5 patent rights. Financial details of the agreement were not disclosed. The license covers various aspects of the specific G-Protein-Coupled Receptor (GPCR), known as C
GAITHERSBURG, Md., May 23 /PRNewswire/ -- Panacos Pharmaceuticals, Inc. today announced that it has been awarded a Phase I Small Business Innovative Research (SBIR) Grant for $125,000 by the National Institutes of Health (NIH). The award, from the National Institute of Allergy and Infectious Diseases of NIH, will help
NEW HAVEN, Conn., May 22 /PRNewswire/ -- Achillion Pharmaceuticals today reported the successful completion of a Phase 1b/2 clinical trial demonstrating potent antiviral activity of the Company s lead product candidate, ACH-126,443 (Beta-L-Fd4C) in patients with chronic hepatitis B (HBV) infection. ACH-126,443 produced
SAN FRANCISCO, May 21 /PRNewswire/ -- A fellowship program designed to increase the number of minority physicians involved in AIDS-related clinical care will be expanded next spring to the University of California, San Francisco, AIDS Research Institute (UCSF-ARI), and Kaiser Permanente. For the past four years, the Ar
LOS ANGELES, May 21 /PRNewswire/ -- AIDS Healthcare Foundation (AHF) announced today that it would bar GlaxoSmithKline (GSK) drug sales representatives from its outpatient facilities throughout the U.S. AHF, which is the nation s largest provider of specialized HIV/AIDS medical care, took the unprecedented action to pr
SEATTLE, May 21 /PRNewswire/ -- Jessye Norman, one of the world s most celebrated opera singers, is raising her distinguished voice on behalf of more than 13 million children orphaned due to the HIV/AIDS pandemic, recently addressed at the United Nations Special Session on Children. In a newly released PSA for World Vi
WASHINGTON, May 21 /PRNewswire/ -- Drawing over 300 participants from across the nation, the Ethiopian Community Development Council s (ECDC) eighth national conference, African Refugees: The Quest for Solutions in a Changing World, held May 13-15 in Washington, D.C., ended with a unanimously approved resolution to aff
SEVILLE, Spain , May 21 /PRNewswire-FirstCall/ -- (World Federation of Haemophilia Congress) -- Baxter BioScience today announced the launch of the BAXJECT needleless transfer device (BAXJECT), a safer, faster and easier way to prepare haemophilia medication without the use of sharp needles or fear of accidental injury
NEW YORK, May 21 /PRNewswire/ -- Despite understanding genital herpes is a highly contagious and lifelong sexually transmitted disease (STD), less than one in five people surveyed (16%) say they get tested for the disease. A sample of people in New York, Chicago, Atlanta and San Diego were surveyed to gauge their attit
SAN FRANCISCO, May 20 /PRNewswire/ -- The Digestive Disease Week (DDW) meeting in San Francisco this week will bring together an assembly of physicians and researchers in the fields of gastroenterology and hepatology. One of the topics at the meeting will be investigational treatments for hepatitis C, a blood-borne vir
CAMBRIDGE, Mass., May 17 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced the results of its Annual Meeting of Stockholders, which was held today. The Company also provided an update on its product pipeline. At the meeting, shareholders re-elected Roger Brimblecombe, Donald Conklin
BETHESDA, Md., May 17 /PRNewswire/ -- May 18th marks the Fifth Annual HIV Vaccine Awareness Day, which highlights research advances and the challenges of the HIV/AIDS pandemic, and underscores why developing preventive HIV vaccines offers the best hope for controlling the AIDS pandemic. Thousands of volunteers worldwid
Rockland, MA, May 16, 2002 - Serono, Inc. has recently become aware of a counterfeit lot of Serono s Serostim(R) [somatropin (rDNA origin) for injection]. The counterfeit material has been packaged to appear as drug product lot number S810-1A1. This is not a legitimate Serostim(R) lot number. Serono has notified the ap
LOS ANGELES, May 16 /PRNewswire/ -- Out Wit. Out Play. Out Last ... and Out Bid ... Make the winning bid to out last fellow Survivor fans to become the lucky owner of priceless memorabilia and props from Survivor: Marquesas. Coveted items from the Survivor series will be auctioned on eBay following the
NUTLEY, N.J., and DURHAM, N.C., May 16 /PRNewswire-FirstCall/ -- Roche and Trimeris, Inc. (Nasdaq: TRMS) today announced positive 24-week results from the second pivotal Phase III study of T-20 (TORO 2), just four weeks after reporting similarly positive 24-week results from the first Phase III study of T-20. Together,
Johannesburg - Save the Children today launched a report entitled Childhood Challenged, South Africa s children, HIV/AIDS and the corporate sector. The report summarises research into the extent to which South African companies are engaging with the issue of HIV/AIDS affected children. It makes the case for why compani
MULBERRY, Fla., May 15 /PRNewswire-FirstCall/ -- Food Technology Service, Inc. (Nasdaq: VIFL) (FTSI), the leader in making foods safer through irradiation, announces the introduction of I-Care Foods(TM). I-Care Foods(TM) is a full-line of chicken, turkey, beef, and eggs that are irradiated to remove pathogens such as S
TORONTO, May 15 /PRNewswire-FirstCall/ - Dimethaid Research Inc. (TSE:DMX) today announced that it has completed the agreement to acquire Oxo Chemie AG of Switzerland . This US$36.96 million acquisition will expand its existing product pipeline to include a new immune-regulating platform drug, known as WF10, currently
YONKERS, N.Y., May 15 /PRNewswire-FirstCall/ -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that Mark H. Kaplan, MD, has joined the Company s Scientific Advisory Board. Dr. Kaplan brings specialized expertise in AIDS treatment and research, including the study of new therapeutic agents, to
NEW YORK, May 15 /PRNewswire/ -- Seth F. Berkley, MD, President and CEO of the International AIDS Vaccine Initiative (IAVI), released this statement in response to the US Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2002. The proposed legislation authorizes an increase in US government funding for inter
SACRAMENTO, Calif., May 14 /PRNewswire/ -- AIDS Healthcare Foundation -- the nation s largest AIDS organization -- today praised Governor Davis brave leadership for keeping his pledge in the face of massive state-wide cuts to protect Californians living with HIV/AIDS. With so much pain in these cuts to so many Californ
NEW YORK, May 14 /PRNewswire/ -- Leading Christian HIV/AIDS experts from around the world will gather on May 17 and 18 in New York to examine the emerging role the Christian community must play in helping alleviate the growing AIDS pandemic sweeping across the African continent and now into Asia. The time has come to c
HUNTINGDON VALLEY, Pa., May 13 /PRNewswire/ -- Biosyn, Inc. announced today at the Microbicides 2002 Conference in Antwerp, Belgium , successful results of two clinical studies for Savvy(R) (C31G intra-vaginal gel), currently in development as a contraceptive and for the prevention of sexually transmitted diseases (STD
CHICAGO, May 13 /PRNewswire/ -- A coalition of advocacy groups today urged the Illinois Department of Public Aid to maintain access to pharmaceuticals for Medicaid patients in Illinois. The IDPA has begun implementation of a plan that would require Medicaid recipients to obtain prior authorization before receiving any
PHILADELPHIA, May 13 /PRNewswire/ -- GayBINGO, the region s wildly popular HIV/AIDS fundraising event will mark its 6th anniversary this Saturday, May 18th at 7 p.m. at the Gershman Y, Pine & Broad Streets in Center City. GayBINGO s success is largely due to the combination of stage entertainment, bingo prizes, and
ST. PAUL, Minn., May 13 /PRNewswire/ -- St. Paul, Minn. based BioErgonomics, Inc. (BioE) recently received a patent for technology that makes detection and identification of diseases such as Hepatitis C and HIV possible at a much earlier stage of infection. U.S. Patent 6,383,740 protects BioE s method for the simultane
CARLSBAD, Calif., May 13 /PRNewswire-FirstCall/ -- The Immune Response Corporation (Nasdaq: IMNR) announced today publication of data suggesting that immune responses to therapeutic immunization with REMUNE(R) were more optimal in HIV infected patients with high CD4 cell counts and low virus levels. The article Predict
LONG BEACH, Calif., May 13 /PRNewswire/ -- Local HIV positive spokespersons will share their personal stories featured in an innovative HIV prevention campaign launching in Long Beach and Orange County. The regional campaign will join existing activities in Los Angeles, San Francisco and Boston. The HIV STOPS WITH ME c
SAN DIEGO, May 13 /PRNewswire/ -- Agouron Pharmaceuticals, Inc., a Pfizer Company (NYSE: PFE), today launched Fighting HIV through R&B, a novel HIV testing program that offers free R&B concert tickets for those individuals who get tested for HIV. The program will be available at participating community clinics
Johannesburg - As corporate South Africa begins to work together to develop and fund sustainable solutions to HIV/AIDS, Gaby Magomola and Clem Sunter (SABCOHA Governors) invite you to a breakfast presentation of key findings by Deloitte & Touche Human Capital Corporation and SAVE the Children. This is the firs
PHILADELPHIA, May 10 /PRNewswire/ -- GlaxoSmithKline (NYSE: GSK) announced today that the company has received four reports of suspect bottles containing 60 tablets of Combivir (R) (lamivudine plus zidovudine) that actually contained another medicine, Ziagen
SEATTLE, May 10 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced that Dr. Richard D. Klausner has been named Executive Director of the foundation s global health program. Dr. Klausner is the former Director of the National Cancer Institute (NCI) where he led the nation s cancer program. We are de
NEW YORK, May 9 /PRNewswire/ -- In a keynote speech today at the United Nations General Assembly Special Session (UNGASS) on Children, Bill Gates, co-founder of the Bill & Melinda Gates Foundation, called for a dramatic increase in leadership and resources from developed countries to improve the health of children
LOS ANGELES, May 7 /PRNewswire/ -- LA Architect, the only magazine serving the Southern California design community, today announced that its gala benefit on May 18, 2001 from 6 p.m. to 10:00 p.m. at the Southern California Institute of Architecture (SCI-Arc), will include art for a silent auction from notable artists
BOUNTIFUL, Utah, and MANSFIELD, Mass., May 7 /PRNewswire/ -- Specialized Health Products(R) International, Inc. (OTC Bulletin Board: SHPI) today announced that Kendall, a business unit of Tyco Healthcare, has initiated its U.S. market launch of a proprietary line of safety syringe needles, based upon the FlexLoc(R) saf
NEW YORK, May 7 /PRNewswire/ -- Religious leaders from the world s major faith traditions today decried the intolerable conditions experienced by millions of children worldwide and demanded the international community meet children s basic needs. Leading Buddhist, Christian, Hindu, Indigenous, Jewish and Muslim leaders
BALTIMORE, May 7 /PRNewswire/ -- As world leaders gather in New York this week to consider how to improve the lives of young people, researchers at the Johns Hopkins University Center for Communication Programs (JHU/CCP) released a new report showing how to reach young people with communication programs designed to enc
BALTIMORE, MD, May 7 /PRNewswire-FirstCall/ - Stressgen Biotechnologies Corporation today presented new research results which further validate the Company s mechanism of action for its patented heat shock protein (Hsp) fusion platform technology for the treatment of viral infections and cancer, at the 5th Annual Confe
PLEASANTON, Calif., INDIANAPOLIS and VENLO, The Netherlands , May 7 /PRNewswire-FirstCall/ -- Roche Molecular Systems, Inc. (RMS), a business area of Roche Diagnostics and Roche Diagnostics Corporation (RDC), the US sales and marketing arm of Roche Diagnostics, and QIAGEN GmbH, a wholly owned subsidiary of QIAGEN N.V.
SOUTH SAN FRANCISCO, Calif., May 7 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced that it has launched PhenoScreen(TM), a new high throughput screening product designed to help drug companies more quickly and cost-efficiently screen clinical drug candidates for HIV. Developed in response to in
BALTIMORE, Md., May 6 /PRNewswire/ -- Leading vaccine scientists from around the world are meeting today in Baltimore for the Fifth Annual Conference on Vaccine Research and will report on the latest research on familiar killers such as pneumococcal, meningococcal, and Group A streptococcal disease, influenza, hepatiti
CHICAGO, May 6 /PRNewswire-FirstCall/ -- The Female Health Company today announced that it has received a grant from the British Government for marketing and manufacturing the Female Condom in India in partnership with Hindustan Latex Limited (HLL). The grant from the Business Linkages Challenge Fund (BLCF) will suppor
STOCKHOLM, Sweden , May 6 /PRNewswire/ -- Swedish biotechnology firm Bioption AB is partnering with the International AIDS Vaccine Initiative (IAVI) to develop and test a new approach for vaccines that can train the immune system to protect against HIV/AIDS. The vaccines are being built from a proprietary technology, S
SEATTLE, May 3 /PRNewswire/ -- Save the Children and CARE today announced a $1 million grant from the Bill & Melinda Gates Foundation to provide emergency food aid for more than two million people -- many of them children -- who are suffering from starvation in the southern African country of Malawi .
DURHAM, N.C., and SHERBROOKE, Quebec, May 3 /PRNewswire-FirstCall/ -- Trimeris, Inc. (Nasdaq: TRMS) and NEOKIMIA INC. today announced the execution of a collaborative agreement to discover and develop small molecule fusion inhibitors of the human immunodeficiency virus (HIV). Under the terms of the agreement, Trimeris
BENICIA, Calif. and CLEARWATER, Fla., May 3 /PRNewswire/ -- AcroMetrix Corporation announced today at the 18th Clinical Virology Symposium that it is introducing a new set of quality control products for laboratories conducting genotypic analyses to identify drug resistance mutations of HIV. NAC HIV Drug Resistance Gen
Ugandan First Lady Honored for Her Work in the Fight Against HIV/AIDS and Her Tireless Work on Behalf of Ugandan Children Orphaned by AIDS - U.S. Senator Dennis DeConcini (Ret.), U.S. Senator Steve Symms (Ret.), Join International Coalition including AIDS Action, AIDS Healthcare Foundation, AHF Global Immunity and the
BLOOMFIELD, N.J., May 2 /PRNewswire-FirstCall/ -- Alfacell Corporation today announced preclinical results which demonstrate that ONCONASE(R) exerts its anti-viral activity at two stages in the HIV-1 life-cycle. These findings have been published in the April 26, 2002 issue of the Journal of Biological Chemistry. The m
NEW YORK, May 1 /PRNewswire/ -- For the first time in its 15-year history, The New York Women s Foundation will give a total of $1 million in grants to neighborhood non-profit groups helping the City s low-income women and girls. In front of over 2,000 women supporters, 35 women-run organizations will receive grants at
ROCKVILLE, Md., May 1 /PRNewswire/ -- A nationwide study sponsored by the Agency for Healthcare Research and Quality (AHRQ), shows that black and Hispanic HIV patients are only about half as likely as non-Hispanic whites to participate in clinical trials of new medications designed to slow the progression of the diseas
LONDON, May 1 /PRNewswire/ -- Deutsche Bank, BASF, Anglo American and British American Tobacco were just some of the companies delivering clear messages on best practice in corporate responsibility last week at the Ethical Corporation Europe 2002 conference. Hans Michael Holz, Global Head of Sustainable Development at
REDWOOD CITY, Calif., May 1 /PRNewswire-FirstCall/ -- Genelabs Technologies, Inc. (Nasdaq: GNLB) announced today that it has entered into a collaboration with the University of Iowa Research Foundation (UIRF) to study the impact of the hepatitis G virus (HGV, also known as GB virus C, or GBV-C) on human immunodeficienc
NUTLEY, N.J. and PLEASANTON, Calif. -- 138 projects in Pharma research and 74 projects in Pharma development -- 48 new molecular entities (NMEs) in pipeline -- 35% increase in the number of NMEs in development portfolio over the past 12 months -- Filing of 17 new drug applications and several additional indications for
- Preliminary Clinical Data for Albutropin(TM) And Albuferon(TM)-alpha Phase 1 presented - Funding Assured, with $1.6 Billion in Cash and Equivalents - ROCKVILLE, Md., April 30 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today told approximately 200 financial analysts in New York that the compa
VANCOUVER - AnorMED Inc. (TSE:AOM) announced today that its licensee, Shire Pharmaceuticals Group plc, has submitted a new drug application (NDA) to the U.S. Food and Drug Administration ( FDA ) for Foznol (likely to be renamed Fosrenol, lanthanum carbonate) as a treatment for elevated blood phosphate levels, in patien
NEWTOWN, Pa -- AxCell Biosciences, a subsidiary of Cytogen Corporation (Nasdaq: CYTO), today announced the signing of a research collaboration with Irwin Gelman, Ph.D., of the Mount Sinai School of Medicine (MSSM) to identify molecules useful for treating HIV-associated nephropathy (HIVAN). Under the terms of the agree
WORCESTER, Mass., April 29 /PRNewswire/ -- Antigen Express, Inc. (AgExp) today announced that the US Patent and Trademark Office has issued to AgExp a new patent, US 6,368,855, concerning its Ii-Suppression Platform Technology. Additionally, AgExp has received a $292,000 Phase I Small Business Innovative Research (SBIR
WASHINGTON -- Clinical and basic science research findings of more than 60 studies are being presented by researchers from the University of Pittsburgh s Thomas E. Starzl Transplantation Institute at the American Transplant Congress, the joint scientific meeting of the American Society of Transplant Surgeons and the Am
ABBOTT PARK, Ill., April 26 /PRNewswire-FirstCall/ -- At the annual meeting of Abbott Laboratories (NYSE: ABT) shareholders today, Chairman and Chief Executive Officer Miles D. White highlighted the company s scientific efforts; the successful integration of Knoll; and the performance of its two business groups, pharma
KERNVILLE, Calif., April 26 /PRNewswire/ -- Senior insurance agent and Certified Senior Advisor (CSA) Harry Thal kept receiving phone calls from clients and other insurance agents regarding the lack of prescription drug coverage provided by Medicare, Senior HMOs and of course, persons with no health insurance. In respo
SAN DIEGO, April 25 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN), a biotechnology company focused on the development of pharmaceutical products using multiple, specific epitopes to activate the body s immune system, today announced that it is advancing its communications program with the financial community w
WASHINGTON, April 25 /PRNewswire/ -- More bad news for the world s chief cheerleader and funder of China s one-child policy: The government of Tanzania has rejected a boatload of defective UNFPA condoms, and announced that they will be destroyed. Despite this embarrassment, UNFPA allies in the State Department are work
VIENNA, Va., April 25 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION (Amex: CVM) and The Naval Medical Research Center (NMRC) announced today that a newly discovered peptide provided 100% protection against malaria infection in a mouse model. Dr. Yupin Charoenvit of NMRC presented these data at the Experimental Biology
NEW YORK, April 25 /PRNewswire/ -- Seth F. Berkley, MD, President and CEO of the International AIDS Vaccine Initiative (IAVI) today released this statement in response to the naming of Dr. Richard Feachem, a member of IAVI s Board of Directors, as Executive Director of the new Global Fund to Fight AIDS, Tuberculosis an
TORONTO - Visible Genetics Inc. (Nasdaq: VGIN) (VGI) today received clearance from the U.S. Food and Drug Administration ( FDA ) for the next generation interpretation software for the TRUGENE(TM) HIV-1 Genotyping Test. The GuideLines(TM) 5.0 Rules, which include the latest data on HIV drug resistance, were reviewed wi
BRISBANE, Calif., April 24 /PRNewswire-FirstCall/ -- The independent committee that oversees the only final-stage clinical trials of AIDS vaccine candidates has once again indicated that the vaccine candidates appear safe and that the trials are being conducted appropriately, VaxGen , Inc. (Nasdaq: VXGN) announced toda
REDMOND, Wash., April 24 /PRNewswire-FirstCall/ -- To generate awareness and raise money for HIV/AIDS prevention, Microsoft Corp. (Nasdaq: MSFT) today announced the MSN(R) Money Celebrity Market Challenge featuring Sir Elton John. Consumers can log on to CNBC on MSN Money and learn how to improve their stock-picking sk
SOUTH SAN FRANCISCO, Calif., April 24 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced that the Company signed an expanded agreement with GlaxoSmithKline (NYSE: GSK) to use ViroLogic s proprietary HIV resistance testing technology in the Phase III clinical development of an investigational HIV p
ISELIN, N.J., April 23 /PRNewswire-FirstCall/ -- Richard Jay Kogan, chairman and chief executive officer of Schering-Plough Corporation (NYSE: SGP), told shareholders at the company s annual meeting here today that Schering-Plough has accomplished a great deal on several fronts during the past year: addressing manufac
VIENNA, Va. and NEW ORLEANS -- Scientists from the laboratory of Dr. Noel Rose in The Johns Hopkins University Department of Pathology and CEL-SCI CORPORATION (Amex: CVM) today presented at the Experimental Biology 2002 meeting, data that could lead to development of a treatment for autoimmune myocarditis, a life threa
EMERYVILLE, Calif. -- Chiron Corporation (Nasdaq: CHIR) today named William G. Green, 57, as president of Chiron s Blood Testing division. Based in Emeryville, Mr. Green, who has been serving as Chiron s general counsel, will be responsible for the commercial operations of Chiron s blood testing business. He will repor
VANCOUVER - AnorMED Inc. (TSE:AOM) is pleased to announce the appointments of Mr. Paul Brennan as Vice President Business Development; Dr. Renato Skerlj as Vice President Chemistry; and Dr. Robert Schooley as a new member of the Company s Scientific Advisory Board. We are very pleased that Mr. Brennan will be joining o
NEW YORK -- The Balm In Gilead announces its 4th Annual Black Church HIV/AIDS Training Institute May 28-31, 2002, in its vigorous effort to continue its national and international mission of empowering churches throughout the African Diaspora to become more prominent in the battle against the AIDS epidemic. The Black C
SACRAMENTO, Calif. -- Africamix was today delighted to announce that California State University, Sacramento has officially been selected as the first host venue of its touring arts and music festival designed to help combat child abuse and neglect. California State University, Sacramento had keenly accepted the appoin
SANTA ANA, Calif. -- Donner Corp. International (DCI) announced today that it released its Speculative Buy Recommendation on Amarillo Biosciences, Inc. (OTC Bulletin Board: AMAR). Donner issued the report at http://www.donnercorp.com stating the favorable research and results in clinical trials of the company s patente
WASHINGTON -- U.S. Representative Barbara Lee (D-CA) and members of the Congressional Black Caucus (CBC) announced on Thursday, April 18, 2002, the introduction of the New Partnership for Haiti resolution at a press conference at the U.S. Capitol. The resolution urges the Bush Administration to end any aid embargo agai
LONDON, -- The Female Health Company (OTC Bulletin Board: FHCO) announced that its subsidiary, The Female Health Company (UK) plc, has received the prestigious Queen s Award for Enterprise, the highest honor that can be bestowed on a UK business. The award, given in the Queen s Golden Jubilee year, has been made in rec
NUTLEY, N.J. -- Roche today announced clinical study results indicating that HIV patients who modified their twice-daily protease inhibitor regimen of FORTOVASE(R) (saquinavir soft gel capsules) with ritonavir (FORTOVASE/r) by increasing the FORTOVASE dose and minimizing the ritonavir dose were able to maintain viral s
WASHINGTON, April 18 /PRNewswire/ -- Two years ago, the historic Jubilee 2000 campaign gained international attention with the help of rock star Bono and religious leaders like the Pope and Archbishop Desmond Tutu. Jubilee 2000 has become Jubilee USA Network, and this broad coalition of labor, religious and development
NEW YORK, April 18 /PRNewswire/ -- Calling the company s current AIDS treatment programs meager , religious and union shareholders are challenging Abbott Laboratories to make life-saving HIV/AIDS medicines accessible and affordable in African countries where AIDS is pandemic. Eight institutions are sponsoring a shareho
NUTLEY, N.J. -- Roche announced that it has signed a licensing agreement with Medivir, a Swedish biotechnology company, for MV026048, an innovative treatment in development for HIV. A novel non- nucleoside reverse transcriptase inhibitor (nNRTI), MV026048 is currently in pre-clinical development and is expected to ente
NUTLEY, N.J. and DURHAM, N.C., April 18 /PRNewswire-FirstCall/ -- Roche and Trimeris, Inc. today announced positive 24-week results from the first pivotal Phase III study of T-20, the furthest in clinical development of an investigational class of antiretrovirals called fusion inhibitors. The results from this first st
NEW YORK -- According to new findings from a national survey conducted by the Kaiser Family Foundation for MTV, more young people cite sexual health as a top concern than any other issue, and three in four say they are not getting all the information they need to make informed and responsible sexual health decisions. I
MEDFORD, Mass., April 16 /PRNewswire/ -- Privately-held Consensus Pharmaceuticals, Inc. announced today the award of a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health in Bethesda, MD. The grant to Con
SAN MATEO, Calif., April 15 /PRNewswire-FirstCall/ -- SciClone Pharmaceuticals (Nasdaq: SCLN) today announced the first patients in its ZADAXIN U.S. phase 3 hepatitis C clinical trials have been enrolled and are receiving treatment. The injection of the first patients in our U.S. phase 3 clinical trials represents the
NEW YORK -- Two decades of mass death have burned the letters HIV deep into our psyches, but few Americans have even heard of the liver-damaging HCV -- the hepatitis C virus. Doctors says the virus now kills 10,000 Americans each year, and the annual toll could reach 30,000 by the end of the decade. That s twice the nu
VIENNA, Va. -- CEL-SCI Corporation (Amex: CVM) has aggressively reduced expenditures following the conclusion of the manufacturing validation program for its immunotheraphy product Multikine. During the last quarter of 2001, CEL-SCI spent about $900,000 per month to achieve its goals. By the middle of May of this year,
BERNARDSVILLE, N.J. -- Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) announced today, April 11, 2002 that Resurgex(TM), its multi-component nutritional supplement designed to assist in maintaining lean muscle, decrease oxidative stress,
The United Democratic Movement Youth Vanguard (UDMYV) rejoices with all South Africans that Nkosi Johnson, who died last year, is to be honoured with the World s Children s Prize for the Rights of the Child. We especially would like to thank and honour Ms Gail Johnson, Nkosi s foster-mother, for her diligent and contin
KEYSTONE, Colo., April 11 /PRNewswire-FirstCall/ -- Promising data from preclinical studies utilizing an adeno-associated virus (AAV) vector for a novel AIDS vaccine candidate were presented earlier this week by Philip Johnson, MD, President of Columbus Children s Research Institute on the campus of Columbus Children s
NUTLEY, N.J., April 10 /PRNewswire/ -- New research published in the April 11th edition of The New England Journal of Medicine shows that VALCYTE(TM) (valganciclovir) tablets are as effective as CYTOVENE(R) (ganciclovir) intravenous (IV) therapy for the treatment of cytomegalovirus (
SOUTH PASADENA, Calif., April 10 /PRNewswire-FirstCall/ -- Viral Genetics (OTC Bulletin Board: VRAL) is pleased to announce that it has received confirmation from its Mexican agents, SAVSA and Labortorios Senosiain, S.A. de C.V., that the final form of the companies joint submission of a New Drug Application ( NDA ) re
BOSTON -- Pfizer s Diflucan (fluconazole) currently dominates the antifungals market, thanks to a good safety profile, relatively few drug-drug interactions, interchangeable oral and intravenous formulations, and a highly successful marketing campaign. As generic competition erodes fluconazole sales, beginning in 2004,
LOS ANGELES -- Over one thousand, one hundred compassionate and brave people have now registered to participate in the ninth annual California AIDSRide, an extraordinary journey of kindness and a powerful way for people to put their own sweat and tears into the AIDS crisis. This year s event will take place from June 2
BLOOMFIELD, N.J. -- Alfacell Corporation (OTC Bulletin Board: ACEL) today announced that Dr. Martin Michaelis of the Institute of Medicinal Virology at Johann Wolfgang University in Frankfurt, Germany is presenting results confirming that ONCONASE(R) significantly inhibits the replication of the HIV virus (the causativ
PITTSBURGH -- Actress Sharon Stone, leading healthcare advocate and Chairman of the Campaign for AIDS Research, The American Foundation for AIDS Research, has been named this year s recipient of The Global Conference Institute s Healthcare Humanitarian Award. The Award, which was established in 1998, recognizes one ind
LOS ANGELES, April 9 /PRNewswire/ -- Struggling with the burden of a significant fund-raising shortfall, yet intent on maintaining its commitment to people living with HIV/AIDS, Project Angel Food today announced it has received emergency corporate funding to continue a successful home-delivered meals program for Hispa
ABBOTT PARK, Ill. -- Abbott Laboratories (NYSE: ABT) announced today it has been awarded a multi-year contract as the exclusive supplier of six infectious disease tests used for screening blood donated to the American Red Cross. The tests consist of markers for hepatitis, HIV and other retroviruses. This agreement
KEYSTONE, Colo. -- ProdiGene, Inc., a leader in the development and manufacturing of recombinant proteins in transgenic plant systems, announced here today at the Keystone Symposia, that it successfully expressed a sub unit vaccine in maize that is expected to produce an immune response to simian immunodeficiency virus
The people of this country can only judge its government, based on what they see, hear and experience and it is seems from ANC government s action, or rather lack of action, that it does not take seriously the decision by the Constitutional Court that it provide Nevirapine, in state hospitals with the capacity to do so
TORONTO -- Visible Genetics Inc. (VGI) (Nasdaq: VGIN) reported today that it expects 2002 first quarter revenues to be in the range of $4.2 million to $4.4 million, which is within the previously announced range of expected revenues for the quarter. This represents an approximate 35% increase over fourth quarter 2001 r
WASHINGTON, April 8 /PRNewswire/ -- The following was released today by ActionAid USA: WHO: With special guests, Actor Danny Glover, Congresswoman Barbara Lee (D-CA), and Jackie Bataringaya of ActionAid, ActionAid USA, The Global AIDS Alliance, Student Global AIDS Campaign and RESULTS invite you to attend a photo exhib
Pleasanton, Calif., Roche Diagnostics announced today that it has received registration for its COBAS AmpliScreenR HIV-1, v1.5 Test within Italy . This assay utilizes Polymerase Chain Reaction (PCR) technology, the worldwide leading Nucleic Acid Amplification Technology (NAT). Roche received this approval from the Mini
CARLSBAD, Calif. -- The Immune Response Corporation (Nasdaq: IMNR) today announced that its Board of Directors has declared a 1-for-4 reverse stock split relating to its outstanding shares of common stock, subject to approval of the Company s stockholders at the Company s annual meeting to be held on May 23, 2002. The
LONDON -- HelpAge International will launch State of the world s older people 2002 in Madrid on 8 April 2002 to coincide with the opening of the Second World Assembly on Ageing. The report reflects the views and experiences of older people, as expressed in consultations held in developing countries and in east and cent
NEW YORK -- Harvard University Professor Jeffrey D. Sachs has been named director of the Columbia University Earth Institute, effective July 1, 2002. Sachs, who serves as an economic advisor to governments in Latin America, Eastern Europe, the former Soviet Union, Asia and Africa as well as to the United Nations, is wi
SEATTLE, April 5 /PRNewswire/ -- Monique Payton, along with some other Seattle Sonic wives and high-profile community women, have teamed up to create Red, White & Blues-an evening of blues music, wine tasting and plenty of Sonic camaraderie to benefit Lifelong AIDS Alliance, a Northwest foundation dedicated to the
WASHINGTON -- 1,000 people with AIDS, public health experts, religious leaders and other activists, joined by actor Danny Glover and Rep. Barbara Lee (D, Oakland), will rally at the Capitol steps Wednesday, April 10, 12:30 PM. The demonstrators will carry a giant alarm clock, declaring that time is up for Congressional
LONDON -- Having successfully completed first-stage human testing, a pair of vaccines designed to mobilize the immune system to protect against HIV and AIDS today advanced to second-stage trials in the UK. The vaccines are the only in human testing that are tailored for variants of HIV common where the infection rate i
The United Democratic Movement (UDM) welcomes the Constitutional Court s refusal to give government leave to appeal against a Pretoria High Court execution order demanding that it provide the anti-retroviral drug nevirapine in state hospitals with the capacity to do so between now and the outcome of a further court hea
SOUTHFIELD, Mich. -- Planned Parenthood of Southeast Michigan will present Kati Marton, United Nations Chief of Outreach, as the keynote speaker at their annual luncheon on Thursday, May 16, 2002. This eighth annual fundraising luncheon will be held at the Ambassador Hotel in Southfield. The event is typically a huge s
VIENNA, Va., April 3 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION (Amex: CVM) today announced that it will be presenting at the American Stock Exchange s upcoming online conference, Where Savvy Investors Meet Undiscovered Companies. You are invited to listen to management s slide presentation that will be Webcast live
CAMBRIDGE, Mass. -- Therion Biologics has expanded its Board of Directors with the appointments of Peter R. Wolfe, M.D., Partner and Director of Research at Pacific Oaks Medical Group, and Trudie Resch, Partner of CDP Sofinov. These additions strengthen Therion s Board by bringing to the company Dr. Wolfe s clinical ex
CARLSBAD, Calif., April 3 /PRNewswire-FirstCall/ -- The Immune Response Corporation (Nasdaq: IMNR) is pleased to announce that at the Special Meeting of Stockholders held on April 2, 2002 at the Company s offices, the stockholders of the Company approved the November 2001 financing and subsequent financing proposal.
CARLSBAD, Calif., April 3 /PRNewswire/ -- Ontogen Corporation today announced the creation of its Oncology Advisory Group (OAG) that consists of leading experts in basic and clinical oncology research. The OAG will provide scientific and strategic guidance to Ontogen s management team regarding its growing portfolio of
TOKYO, April 2 /PRNewswire/ -- Chugai Pharmaceutical Co., Ltd. announced today that its wholly owned subsidiary, Gen-Probe Incorporated, has filed Form 10 with the Securities and Exchange Commission in connection with proposed spin-off from Chugai Pharmaceutical and stock exchange listing in the United States
HARRISBURG, Pa. -- Gov. Mark Schweiker has proclaimed April 1-7 as Public Health Week in Pennsylvania. As state leaders and public health officials, we have no greater responsibility than promoting and protecting the health and safety of Pennsylvanians, Gov. Schweiker said. I commend Health Secretary Robert Zimmerman,
RANCHO SANTA MARGARITA, Calif. -- Trinity Medical Group USA, Inc. (OTC Bulletin Board: TMGU) announced today that the Thai National Ethical Committee, Ministry of Public Health, has approved an advanced study of REMUNE(R), an Immune-Based Therapy to treat HIV-infected individuals. The study, known as IB3101, is intende
ROSEVILLE, Minn. -- On February 26, 2002 the U.S. Patent and Trademark Office granted Parker Hughes Institute a patent (U.S. patent No. 6,350,736) for Stampidine, a new anti-AIDS drug developed at the institute. Parker Hughes Institute has completed all pre-clinical research and development related to Stampidine and is
BOCA RATON, Fla. -- Nabi Biopharmaceuticals (Nasdaq: NABI) today announced that the Food and Drug Administration ( FDA ) released for sale the initial production of Nabi-HB(TM) [Hepatitis B Immune Globulin (Human)] manufactured at Nabi Biopharmaceuticals Boca Raton, Florida biopharmaceutical manufacturing facility. Na
BRISBANE, Calif. -- Celltrion Inc., a joint venture owned by VaxGen , Inc. (Nasdaq: VXGN) and a group of South Korean investors, announced the appointment of directors and interim senior officers to lead the company in its establishment of facilities for the manufacture of VaxGen s AIDS vaccine candidates. James P.
MEMPHIS, Tenn. -- St. Jude Children s Research Hospital today announced its Multicultural Outreach Initiative, a program designed to share information with minority communities about the groundbreaking research conducted by St. Jude scientists to treat and cure children who suffer from catastrophic diseases. Some of th
SALT LAKE CITY -- Medical Discoveries, Inc. (OTC Bulletin Board: MLSC) announced today that it has entered into an advisory agreement with Euronet International, Inc., a New York City-based business and financial advisory firm. Under the terms of the agreement, Euronet International will seek to initiate a private plac
BERNARDSVILLE, N.J. -- Millennium Biotechnologies, Inc., a wholly owned subsidiary of Regent Group, Inc. (OTC Bulletin Board: RGII), today announced they have received from the Centers for Medicare and Medicaid Services (CMS) a HCPCS coding for their nutritional supplement, Resurgex(TM). HCPCS coding is required for Me
MULBERRY, Fla. -- Food Technology Service, Inc. (Nasdaq: VIFL), the nation s most experienced food irradiation company, today announced that Robert Windom, M.D. has joined the company as Senior Medical Advisor. Windom served as U.S. Assistant Secretary for Health, the highest-ranking physician in the Federal government
SOUTH SAN FRANCISCO, Calif. -- ViroLogic, Inc. (Nasdaq: VLGC) today announced it has closed a transaction to sell newly designated shares of 6% convertible preferred stock to several large investors in a private placement resulting in gross proceeds to the company of $10 million. ViroLogic expects to use the proceeds f
The United Democratic Movement (UDM) opposes the proposal that a deputy-minister might be appointed to exclusively deal with the HIV/Aids crisis in South Africa . Such an appointment would only serve as a demotion or downgrading of the very serious issue of HIV/Aids. The management of the issue is supposed to occur at
OKEMOS, Mich. -- Early detection of serious medical conditions is being made in an unexpected place -- the dental office. Because many other diseases can cause specific signs and symptoms in and around the mouth and jaw, dentists see clues that may point to critical health issues. As a result, increasing numbers of den
LOS ANGELES -- Pallotta TeamWorks, charity event organizers, today announced Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), The Diana, Princess of Wales HIV Research Foundation, and HIVSA have signed on as South African beneficiaries of the African AIDSTrek, joining the UCLA AIDS Institute and Emory Vaccine Resear
SOUTHFIELD, Mich. -- The 23rd annual PROJECT HEALTHY LIVING, sponsored by WXYZ-TV/Channel 7, Suzuki, Molina Healthcare and the United Health Organization, a United Way agency, will be held Saturday, April 6 through Saturday, May 11, at more than 100 sites in the City of Detroit and the counties of Lapeer, Livingston, M
SAN DIEGO -- Oncosis, Inc., today announced that it has established a sponsored research agreement with Dr. James F. Leary, Ph.D., and the University of Texas Medical Branch (UTMB) in Galveston, Texas. The agreement will feature development of the company s patented Photosis(TM) technology platform, a novel, automated,
If it is not enough that our fellow citizens suffer from illnesses like, Cholera, TB and HIV/Aids; more and more South Africans are daily exposed to a government which carry other diseases. lack of care and lack of action. This ANC government refuses to acknowledge its errors when it comes to HIV/Aids; the result is th
The UDM welcomes the Pretoria High Court ruling that Government has to provide nevirapine to HIV-positive pregnant women at all state hospitals with the capacity to do so. This must now end the ANC government s insistence to continue with useless talk and debate, instead of action. Government must lead by example, thus
NEW BRUNSWICK, N.J. -- Johnson & Johnson today announced it has signed a definitive agreement to acquire all of the assets of Tibotec-Virco NV, a privately-held biopharmaceutical company focused on developing anti-viral treatments, with several promising compounds in development for the treatment of infectious dise
ALEXANDRIA, Va. -- A simple, cost effective living solution pairing children and the elderly, the two groups most vulnerable to the ravages of the African AIDS pandemic, soon will become a reality in Kenya and serve as a prototype for similar initiatives elsewhere. Before the end of the year, the 100-acre City of Hope
WASHINGTON -- The Washington Business Group on Health (WBGH) and Pfizer /PfizerHealth Solutions today announced a pilot project designed to address health care disparities, particularly targeting cardiovascular disease, in a culturally diverse workforce. It is part of the WBGH s initiative entitled, the WBGH Health Di
ALLSCHWIL, Switzerland and SOUTH SAN FRANCISCO, Calif. -- A landmark study being published in the March 21, 2002 issue of the renowned New England Journal of Medicine highlights the importance of Tracleer(TM) (bosentan) tablets for the treatment of pulmonary arterial hypertension (PAH). The study, known as BREATHE-1 (B
CHICAGO -- Nadine Wong s Bioportfolio is up 26.8% in 2002 vs. a -5.6% loss in the Biotech Index demonstrating the importance of specialization in maximizing sector-specific returns. Get one of her top picks with the potential to post bionic performance! For the complete report and more in-depth market commentary, visit
BOSTON -- The United Nations Association of Greater Boston (UNA-GB) will host a one-day conference, Realizing the Vision: The Global Fund to Fight AIDS, Tuberculosis, and Malaria, on Thursday, May 2, 2002 at the American Academy of Arts and Sciences in Cambridge, Mass. The conference will explore ways to help assure th
YONKERS, N.Y. -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that it has been awarded U.S. Patent No.6,355,226 entitled Topical Treatment of Skin Disease and Eye Afflictions. The patent protects the use of Product R, the non-toxic peptide-nucleic acid immunomodulator developed by Advanced V
FORT COLLINS, Colo. -- Atrix Laboratories, Inc. (Nasdaq: ATRX) announced today that it has commenced Phase II clinical trials for a proprietary formulation of a low dose oral interferon-alpha product for the treatment of oral warts caused by human papilloma virus (HPV) in HIV-infected patients. I am pleased with the sw
LOS ANGELES -- Two Global Health Program staff members, Dr. Gordon Perkin and Suzanne Cluett, from the Bill & Melinda Gates Foundation join 150 people on an African AIDSTrek, a groundbreaking, 75-mile journey through South Africa as they do their part to make a difference in the fight against AIDS. For seven days,
COLORADO SPRINGS, Colo. -- The Gay and Lesbian Fund for Colorado, a fund of the Denver-based Gill Foundation, today announced it made more than $148,000 in grants to Colorado nonprofit organizations during its first two granting cycles of 2002. The 45 grants illustrate the support gay and lesbian philanthropists make t
VIENNA, Va. -- The Institute of Human Virology (IHV) at the University of Maryland, Baltimore, and CEL-SCI Corporation (Amex: CVM) announce the presentation of clinical data for CEL- SCI s immunotherapy drug, Multikine, at the March 2002 Annual Meeting of the Society of Gynecological Oncologists in Miami, Florida. Thes
Distributed by PR Newswire South Africa on behalf of SABCOHA The South African Business Coalition on HIV/AIDS (SABCOHA) is to establish a resource centre and website to assist the private sector in the fight against HIV/AIDS. In particular, SABCOHA will gather information on best practice in the field so that companies
NEW YORK -- Pernessa C. Seele, CEO and Founder of The Balm In Gilead, the leading non-governmental organization dedicated exclusively to mobilizing African American churches in the United States in the fight against HIV/AIDS, will lead a delegation to five African countries beginning April 7 as part of its transatlanti
RESEARCH TRIANGLE PARK, N.C. -- Physicians, patients and scientists who ve been involved from the beginning will commemorate on March 19 the 15-year anniversary of the FDA s approval of the first AIDS drug -- AZT (Retrovir(R)/zidovudine), manufactured by GlaxoSmithKline -- and reflected on
PRAGUE - Progenics Pharmaceuticals (Nasdaq: PGNX) reported that its novel investigational drug, PRO 542, produced a significant antiviral response in HIV-infected individuals who were no longer responding to currently available antiretroviral medications. In treatment-experienced patients, a single dose of PRO 542 redu
Distributed by PR Newswire South Africa on behalf of Brian Pendleton Neiman Marcus will host a South African wine and hors d oeuvres reception in support of Brian Pendleton s fundraising efforts for the Pallotta Teamworks African AIDSTrek, to be held on April 2 -- 8, 2002. As part of his fundraising efforts, Brian Pend
ATHENS, Ga. -- The Southeast s largest indoor beer festival, the 7th annual Classic City Brew Fest, will attract 3,000 beer aficionados from several states who will enjoy open sampling of over 160 of the world s greatest beers on Saturday, April 6, 2002 from 2:30 p.m. to 7 p.m. Held in the exhibit hall of Athens downto
SEATTLE -- Xcyte Therapies, Inc. today announced that the U.S. Patent and Trademark Office (PTO) has issued U.S. patent #6,352,694 covering the Company s core technology used in its products currently in clinical trials in cancer patients. Xcyte Therapies uses this proprietary technology, known as the Xcellerate(TM) Te
WASHINGTON -- The polls may show that President Bush is getting good grades for his war on terrorism, but he is not making the grade in the war on HIV/AIDS, according to a national coalition of AIDS organizations from throughout the United States . As the AIDS pandemic enters its third decade, the coalition, in a lette
SAN DIEGO -- Epimmune Inc. (Nasdaq: EPMN) today announced financial results for the fourth quarter and year ended December 31, 2001. For the fourth quarter 2001, the Company reported revenues of $1.7 million, compared to $0.5 million in the fourth quarter of 2000. Revenues for the year ended December 31, 2001 were $8.2
TARRYTOWN, N.Y. -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its results of operations for the fourth quarter and year ended December 31, 2001. Revenues for the fourth quarter ended December 31, 2001, totaled $2.7 million compared to $3.5 million for the same quarter in 2000. For the year ended Dec
LOS ANGELES -- Fifteen new Promotoras Comunitarias will celebrate the end of five months of training by Planned Parenthood Los Angeles (PPLA) at a graduation ceremony on Wednesday, March 13 at 11 a.m. at Luminarias Restaurant located at 3500 W. Romona Blvd. in Monterey Park. Following the graduation, the Promotoras wil
TEMPLE, Texas -- A prominent obstetrician/gynecologist at Scott & White Memorial Hospital and Clinic today released 10 Tips on discussing sex with children and teen-agers. Just because you may be a tad embarrassed to talk about sex with your kids doesn t mean your kids don t want to hear from you, said Patricia Sul
NEW YORK -- The American Foundation for AIDS Research (amfAR) today announced research grant awards totaling over $2 million for new research on HIV/AIDS, including grants to projects specifically aimed at developing new anti-HIV drugs. Since 1985, amfAR has invested nearly $190 million in support for its programs and
BOSTON -- Vical Incorporated (Nasdaq: VICL) announced that Vijay B. Samant, Vical s Chief Executive Officer, will present today a strategic overview of the company s plans to significantly expand its product development efforts. The presentation is scheduled for 9:00 a.m. Eastern Time at SG Cowen Securities Corp. s 22n
NEW YORK -- AEGiS (AIDS Education Global Information System) announced today the formation of Ask the Doc, an interactive program on its web site, http:/www.AEGiS.org/askdoc. The program is designed to provide general information from physicians on a variety of AIDS-related medical topics. AEGiS has been previously cel
YONKERS, N.Y. -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that it has submitted the results of a Phase 1 study for the topical use of Product R in the treatment of genital warts caused by infection with the human papilloma virus (HPV) to the U.S. Food and Drug Administration (
NEW YORK -- In an effort to raise money and awareness for the fight against HIV/AIDS in the African-American Community, BET and BET.com will team with entertainment industry celebrities to conduct an online auction of signed and/or exclusive memorabilia. The Yahoo auctions event will commence on Monday, March 18th and
LOS ANGELES -- The American Medical Association presented legendary film actress Elizabeth Taylor with an AMA Presidential Citation on Monday for her tireless commitment to advocacy on HIV-AIDS. Calling Taylor s role in addressing AIDS one of her most memorable, AMA President Richard F. Corlin, MD, applauded Taylor for
The United disappointment that the Pretoria High Court granted Government leave to appeal against an order that it should provide the Nevirapine to HIV-positive pregnant women at state hospitals and clinics. The actions of the Department of Health and that of Minister Tshabalala-Msimang in particular, bears testimony t
WARREN, N.J. -- Celgene Corporation (Nasdaq: CELG) announced today that, based on continuing discussions with the FDA , the Company now intends to seek marketing approval for THALOMID(R) (thalidomide) in early stage multiple myeloma patients. In addition to the data from the four trials that have already been prepared
FRAMINGHAM, Mass. -- Genzyme Corp. today reported that total revenues for Genzyme Molecular Oncology (Nasdaq: GZMO) for the fourth quarter of 2001 were $2.6 million, an increase from $1.5 million for the fourth quarter of 2000. For the year, total revenues were $6.6 million, up from $5.7 million reported a year ago. Re
MONTREAL - URRMA Biopharma Inc. (http://www.urrma.com) is pleased to announce the appointment of Luc Mainville to the position of Vice President and Chief Financial Officer. Mr. Mainville graduated from the Universite du Quebec a Montreal (UQAM) in Finance and holds an MBA from McGill University. He also holds a certif
MONTREAL - URRMA Biopharma Inc., (http://www.urrma.com) a private Montreal-based biotech company, is pleased to announce that it has filed a patent on a newly discovered subclass of IgG immunoglobulin with broad diagnostic and therapeutic applications to the diseases caused by HIV and possibly other infectious viruses.
WORCESTER, Mass. -- Microbiotix, Inc. announced today that the US Patent and Trademark Office has issued US Patent No. 6,337,390 entitled Compounds Comprising Sulfated Nonulonic Acid Having Antiviral Activity . This composition of matter patent covers a broad class of antiviral compounds that includes Microbiotix s lea
DURHAM, N.C., March 5 /PRNewswire-FirstCall/ -- Trimeris, Inc. (Nasdaq: TRMS) today announced results for the fourth quarter and fiscal year ended December 31, 2001. For the fourth quarter of 2001, the Company reported a loss of $21.5 million, or $1.24 per share, compared with a loss of $11.1 million ($0.70 per share)
BOCA RATON, Fla., March 5 /PRNewswire-FirstCall/ -- Nabi (Nasdaq: NABI) today announced that it has changed its name to Nabi Biopharmaceuticals. This change recognizes the completion of the company s strategic transition to become a vertically integrated biopharmaceutical company. The company s focus is on the developm
TAMPA, Fla., March 5 /PRNewswire-FirstCall/ -- BBJ Environmental Solutions, Inc. (OTC Bulletin Board: BBJE) is pleased to announce that the U.S. Environmental Protection Agency (EPA) has given its approval for BBJ Spray Disinfectant/Cleaner to be used against Hepatitis B Virus (HBV). Robert Baker, Chairman and CEO of B
LEIDEN, The Netherlands , March 5 /PRNewswire-FirstCall/ -- Dutch antibody and vaccine company Crucell N.V. (Nasdaq, Euronext: CRXL) today said initial data from a Phase I trial involving Merck & Co. Inc s experimental HIV vaccine look encouraging. The HIV vaccine, based on a recombinant adenovirus, is produced on
HALIFAX, NS, March 4 /PRNewswire-FirstCall/ - MedMira announced today that it has received notification of the date for a comprehensive pre-approval inspection by the United States Food and Drug Administration ( FDA ). This is the final stage of the FDA Pre-Market Approval ( PMA ) process for the approval of MedMira s
NEW YORK, March 4 /PRNewswire/ -- M.A.C Cosmetics, the rule-breaking professional cosmetics company, unveiled today an irreverent advertising campaign shot by David LaChapelle, starring music legend and outspoken AIDS activist Elton John, Grammy Award winner Mary J. Blige and rock icon Shirley Manson of the band Garbag
RANCHO SANTA MARGARITA, Calif., March 1 /PRNewswire-FirstCall/ -- Trinity Medical Group USA, Inc. (OTC Bulletin Board: TMGU) announces that as part of its New Drug Application for REMUNE(R) filed in Thailand , the Thai Ministry of Public Health has been presented an independent REMUNE study conducted in
LOS ANGELES, March 1 /PRNewswire/ -- Artists for a New South Africa (ANSA) will present Voices from the Frontline, an evening of art, readings and film about the South African HIV/ADS crisis, Thursday, March 14 from 6 to 9 p.m. at the UCLA Fowler Museum of Cultural History. The event is free and open to the public. Pa
NUTLEY, N.J., March 1 /PRNewswire/ -- Roche today announced results of two new studies of the HIV protease inhibitor FORTOVASE(R) (saquinavir soft gel capsules). One study evaluated FORTOVASE with Kaletra (TM) ( lopinavir / ritonavir ) in 28 treatme
PRINCETON, N.J., March 1 /PRNewswire-FirstCall/ -- Data presented this week at a major HIV medical meeting suggest that the investigational one- capsule, once-daily extended release formulation of Bristol-Myers Squibb s (NYSE: BMY) anti-HIV drug ZERIT(R) ( stavudine ) had similar virologic activity to the currently
SEATTLE, Feb. 28 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) demonstrated its strong commitment to virology with presentations on research from its discovery, clinical development and Phase IV development programs at a top HIV/AIDS meeting held this week in Seattle, Washington. Of particular note
WASHINGTON, Feb. 28 /PRNewswire/ -- Because men from racial and ethnic minority populations face such a high risk of heart disease, diabetes, HIV/AIDS, and other conditions and often lack access to basic care, they are now experiencing a health care crisis, according to a report released today by Community Voices: Heal
CARLSBAD, Calif., Feb. 28 /PRNewswire-FirstCall/ -- The Immune Response Corporation (Nasdaq: IMNR) announced today new data presented this week at the Ninth Conference on Retroviruses and Opportunistic Infections in Seattle. The results were presented by Dr. Fernandez-Cruz, principal investigator at University General
NEW HAVEN, Conn., Feb. 28 /PRNewswire/ -- Achillion Pharmaceuticals, a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative anti-infective agents, today announced the commencement of a Phase 2 clinical study with the Company s lead product candidate, ACH-126,44
SAN DIEGO, Feb. 28 /PRNewswire/ -- Gen-Probe Incorporated today announced that the U.S. FDA has approved its Biologics License Application (BLA) for its amplified nucleic acid test (NAT) to be used by blood banks to simultaneously detect human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV). The comb
EMERYVILLE, Calif., Feb. 28 /PRNewswire-FirstCall/ -- Chiron Corporation (Nasdaq: CHIR) today announced that the U.S. Food and Drug Administration ( FDA ) has approved the Procleix(TM) HIV-1/HCV Assay for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV). The nucleic acid amplification test (NAT)
Distributed by PR Newswire South Africa on behalf of United Democratic Movement The United Democratic Movement (UDM) would add its voice to that of businesses and companies who realise that the scourge of HIV/Aids has, and will exponentially more so, have an effect on the economic status of our country, companies and b
LOS ANGELES, Feb. 27 /PRNewswire/ -- African AIDSTrek participants gear up for a groundbreaking, 75-mile journey through South Africa as they do their part to make a difference in the fight against AIDS. For seven days, 150 individuals have dedicated their lives to the forgotten people of Africa, where it is estimated
LOS ANGELES, Feb. 27 /PRNewswire/ -- To address HIV disclosure and help prevent the spread of HIV in the Latino community, AIDS Project Los Angeles (APLA) recently published Breaking The Silence... Rompiendo El Silencio. The twenty stories in the booklet are self-authored accounts from Latino and Latina HIV/AIDS surviv
WASHINGTON, Feb. 26 /PRNewswire/ -- In announcing his proposal of $135 million for abstinence education programs, President Bush made the following statement today regarding the government s role in educating children about sex education: Abstinence is the surest way and the only completely effective way to prevent unw
LOS ANGELES, Feb. 26 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the nation s largest provider of specialized HIV/AIDS medical care, steps up the urgency of its public awareness campaign to try and get GlaxoSmithKline (GSK), one of the largest AIDS drug manufacturers in the world, to lower the prices and cut the
SAN FRANCISCO, Feb. 26 /PRNewswire/ -- The current controversy regarding the efficacy of HIV prevention programs is just one of the critical issues to be addressed at the 14th annual National HIV/AIDS Update Conference, sponsored by the American Foundation for AIDS Research (amfAR). The conference, to be held March 19-
CARLSBAD, Calif., Feb. 26 /PRNewswire-FirstCall/ -- The Immune Response Corporation (Nasdaq: IMNR) announced today that data presented at the Ninth Conference on Retroviruses and Opportunistic Infections in Seattle on February 25, 2002 suggest that the Company s envelope depleted killed HIV-1 virus when combined with a
SEATTLE, Feb. 26 /PRNewswire-FirstCall/ -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) has selected a humanized form of its PRO 140 antibody for clinical testing as a promising new HIV therapy. PRO 140 works by a novel mechanism not exploited by any of the currently approved HIV agents: it blocks CCR5, a receptor on
VANCOUVER, Feb. 25 /PRNewswire-FirstCall/ - AnorMED Inc. (TSE:AOM) announced today that new clinical data presented at the 9th Retroviral and Opportunistic Infections conference in Seattle on February 25th are the first clinical proof of principle for CXCR4, a chemokine receptor, as a new target in the treatment of HIV
WASHINGTON, Feb. 25 /PRNewswire/ -- Leading healthcare, government and community leaders, today called for a renewed focus on programs which enhance clinical care for African-Americans with HIV/AIDS and increase awareness among clinicians, patients and caregivers about issues as they relate to this community. The most
ATLANTA, Global Odyssey 2002 International Proficiency Testing Conference, Feb. 25 /PRNewswire/ -- AcroMetrix Corporation announced today the introduction of the first comprehensive Hepatitis C Virus (HCV) Genotyping Proficiency Program available to molecular diagnostics laboratories. This newest addition to AcroMetrix
NEW YORK, Feb. 25 /PRNewswire/ -- Sesame Workshop, the non-profit organization that has created such beloved children s programs as Sesame Street, Dragon Tales, and Sagwa, The Chinese Siamese Cat, and Johns Hopkins University Center for Communication Programs (JHU/CCP), a pioneer in the field of strategic, research-bas
ATLANTA, Feb. 25 /PRNewswire-FirstCall/ -- CytRx Corporation (Nasdaq: CYTR) today announced that it has received a $1 million milestone payment due from Merck & Co. , Inc. pursuant to Merck s license of CytRx s TranzFect technology. CytRx s TranzFect technology is incorporated in an experimental DNA-based HIV vacci
PHILADELPHIA, Feb. 25 /PRNewswire/ -- According to the Centers for Disease Control, injection drug use accounted for 49% of new HIV infections in Philadelphia in 1996. Of the 12,775 AIDS cases reported in the city through May 2000, 42% are injection drug use related, with Philadelphia s minority communities among the h
GAITHERSBURG, Md., Feb. 25 /PRNewswire/ -- Panacos Pharmaceuticals Inc. today announced that it has found evidence of new targets for HIV fusion inhibitor discovery. Fusion inhibitors block the first step in virus infection of human cells and represent one of the most exciting new areas for antiviral drug development.
VANCOUVER - AnorMED Inc. (TSE:AOM) announced today that new clinical data presented at the 9th Retroviral and Opportunistic Infections conference in Seattle on February 25th are the first clinical proof of principle for CXCR4, a chemokine receptor, as a new target in the treatment of HIV. Results presented demonstrate
WASHINGTON -- Leading healthcare, government and community leaders, today called for a renewed focus on programs which enhance clinical care for African-Americans with HIV/AIDS and increase awareness among clinicians, patients and caregivers about issues as they relate to this community. The most recent figures availab
SEATTLE, Feb. 24 /PRNewswire/ -- Bill Gates announced today, at the Conference on Retroviruses and Opportunistic Infections, an upcoming trip to Africa by the Bill & Melinda Gates Foundation and The Carter Center that is intended to draw attention to the urgent need for comprehensive strategies to fight HIV/AIDS. T
TARRYTOWN, N.Y., Feb. 22 /PRNewswire-FirstCall/ -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) reported today that it has initiated a Phase IIb clinical trial of its investigational drug methylnaltrexone (MNTX) for the reversal of narcotic-induced constipation, a debilitating problem for many patients treated with o
The United Democratic Movement Youth Vanguard (UDMYV) hopes that the Minister of Finance s, Trevor Manuel, warning that the cost of nationally providing Nevirapine would use up the entire health budget, would not be used as an excuse not to do so at all. The UDMYV recalls offers from international companies and other d
WEST CONSHOHOCKEN, Pa., Feb. 21 /PRNewswire-FirstCall/ -- Expanding its development pipeline, BTG (LSE: BGC), the global technology commercialization company, has acquired a new class of drug candidates targeted to treat advanced and chronic HIV infection. Preclinical studies have demonstrated that PMS 601, the lead ca
LOS ANGELES, Feb. 20 /PRNewswire/ -- AIDSRidesUSA event organizers Pallotta TeamWorks today announced that over 4500 people have signed up for the 2002 AIDSRidesUSA events, which raise money and awareness for HIV/AIDS. Since the inaugural fundraising ride in 1994, over 60,000 men and women have participated in 51 event
PHILADELPHIA, Feb. 20 /PRNewswire/ -- According to the Centers for Disease Control, injection drug use accounted for 49% of new HIV infections in Philadelphia in 1996. Of the 12,775 AIDS cases reported in the city through May 2000, 42% are injection drug use related, with Philadelphia s minority communities among the h
SUNNYVALE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that preclinical study findings published in this week s issue of the Proceedings of the National Academy of Sciences of the United States of America provide evidence that Xcytrin(R) (motexafin gadolinium, a.k.a., ga
WASHINGTON, Feb. 15 /PRNewswire/ -- The National Youth Advocacy Coalition today praises Secretary of State Colin L. Powell for remarks he made last night to teenagers worldwide supporting the use of condoms in preventing HIV infection among sexually active youth. In my own judgment, condoms are a way to prevent infecti
NEW YORK, Feb. 15 /PRNewswire/ -- To draw attention to the growing epidemic of HIV/AIDS in young people, the Adolescent AIDS Program (AAP) at Children s Hospital at Montefiore Medical Center in the Bronx, New York has launched a comprehensive online resource center addressing youth and HIV/AIDS. The online launch coinc
Cheryllyn Dudley MP for the African Christian Democratic Party and Member of the Health Portfolio Committee today said, the planned increase in distribution of free condoms, which will cost tax payers 250 million a year, can only be described as a red herring and abuse of public funds. Responding to reports that the He
PRINCETON, N.J., Feb 14 /PRNewswire/ -- The World Antibacterial, Antifungal, & Antiviral research communities will convene in Princeton, NJ this coming March to attend the 7th Antibacterial Drug Discovery & Development Summit on March 11-12, and the 6th Antifungal Drug Discovery & Development Summit and 3rd
MTV Audiences in the US, India , the Middle East, Italy , UK/ Ireland , Brazil and Russia Ask U.S. Secretary of State Colin Powell Questions About War On Terrorism and Other Global Issues &
FREMONT, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (Nasdaq: CIPH) announced today that it has signed a Collaborative Research and Development Agreement (CRADA) with the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases. The CRADA will focus on The Dis
FREMONT, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (Nasdaq: CIPH) announced today that it has signed a Research and License Agreement with the Aaron Diamond AIDS Research Center (ADARC). This agreement contains detailed workplans to pursue projects related to discoveries and samples provided
SAN FRANCISCO, Feb. 14 /PRNewswire/ -- Aggressive AIDS Prevention, Inc., with the corporate sponsorship of Mayer Laboratories, Inc., is holding a Sweepstakes with prizes of a years supply of Kimono and MAXX brand premium latex male condoms and Aqua Lube personal lubricant during National Condom Week. National Condom We
WASHINGTON, Feb. 13 /PRNewswire/ -- A new internet platform was launched today that will act as a powerful tool in the fight against world poverty and cut costs and improve targeting of international assistance. DevelopmentSpace, a service of ManyFutures, Inc., was switched on today, opening avenues for effective inter
MELVILLE, New York, Feb. 13 /PRNewswire/ -- On February 28, 2002, 100 of the world s foremost photojournalists, representing 21 countries, will take part in one of the most ambitious photographic projects ever attempted: they will fan out across 53 nations to capture the entire African continent on a single day. The be
ROCKLAND, Mass., Feb. 12 /PRNewswire-FirstCall/ -- Serono, Inc. today announced the US launch of SeroJet(TM)(1), a needle-free option for delivering Serostim(R) [somatropin (rDNA origin) for injection], the company s recombinant human growth hormone (rHGH). Serono (SWX Swiss Exchange: SEO & NYSE: SRA) is the only c
ATLANTA, Feb. 12 /PRNewswire-FirstCall/ -- CytRx Corporation (Nasdaq: CYTR) today announced that its TranzFect technology is incorporated in an experimental DNA-based HIV vaccine being developed by Merck & Co. , Inc. (NYSE: MRK) that has now entered Phase I clinical trials. Merck scientists hope the clinical trials
SOUTH SAN FRANCISCO, Calif., Feb. 12 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced an agreement with Panacos Pharmaceuticals, a privately held pharmaceutical company, to utilize ViroLogic s drug resistance assays in the pre-clinical evaluation of Panacos lead HIV drug candidates. Under the te
CHICAGO, Feb. 8 /PRNewswire/ -- Equip for Equality (EFE) has launched a new project called Protection and Advocacy for Beneficiaries of Social Security (PABSS), a federally funded initiative to provide advice to Social Security beneficiaries on their rights to obtain or return to work, as well as advocacy services on t
WASHINGTON, Feb. 7 /PRNewswire/ -- Our country s biggest threat isn t bioterrorism, according to science writer Madeline Drexler. Even worse than the possibility of a large-scale bioterrorism attack is the reality of Mother Nature, who brews up daily her own batch of crafty and deadly bioweapons -- West Nile virus, HIV
SOUTH SAN FRANCISCO, Calif., Feb. 7 /PRNewswire-FirstCall/ -- ViroLogic, Inc. today announced an agreement with Achillion Pharmaceuticals, a privately held pharmaceutical company, to utilize ViroLogic s drug resistance assays to evaluate Achillion s lead product candidate, ACH-126,443 (Beta-L-Fd4C), an L-nucleoside in
NEW YORK, Feb. 7 /PRNewswire/ -- TheBody.com, the leading HIV/AIDS information resource on the Internet, has released an in-depth assessment of women and HIV in the United States . Overwhelmingly poor, and with 60% caring for at least one child under the age of 16, women with HIV are the fastest-growing population in t
NEW YORK, Feb. 6 /PRNewswire Asia/ -- The global search to develop and distribute a vaccine to prevent AIDS was the focus of a high-level workshop, sponsored by the World Economic Forum s Global Health Initiative (GHI). In attendance were business leaders from such diverse sectors as the pharmaceutical, finance, media
SAN DIEGO, Feb. 5 /PRNewswire/ -- Guerilla FilmWorks and The Navajoblack Company are pleased to announce that their first co-production and feature film, living with mimi, will have its world premiere at the Hollywood Black Film Festival 2002 which selected the film as one of 20 feature finalists. Living with mimi will
NEW YORK, Feb. 5 /PRNewswire/ -- The global search to develop and distribute a vaccine to prevent AIDS was the focus of a high-level workshop, sponsored by the World Economic Forum s Global Health Initiative (GHI). In attendance were business leaders from such diverse sectors as the pharmaceutical, finance, media and m
GAITHERSBURG, Md., Feb. 5 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that it has signed a contract with the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under which GenVec will use its proprietary adeno
MARIANNHILL, South Africa , Feb. 5 /PRNewswire/ -- Catholic Medical Mission Board (CMMB), a nongovernmental organization which operates healthcare programs and related support in developing nations, expands its fight against AIDS with the official launch here February 11 of the first of at least three clinics in South
WASHINGTON, Feb. 4 /PRNewswire/ -- President Bush s proposed Fiscal Year 2003 budget includes $31.5 billion for the Department of Housing and Urban Development to help more Americans become homeowners, to provide additional rental assistance, to protect vulnerable people, and to stimulate economic development and job g
PRINCETON, N.J., Feb. 4 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb (NYSE: BMY) today announced the approval in the US of a new one-tablet 600 mg formulation of its widely used once-daily anti-HIV drug SUSTIVA(R) ( efavirenz ). SUSTIVA is a once-daily non-nucleoside reverse transcriptase inhibitor (NNRTI) used
LOS ANGELES, Feb. 4 /PRNewswire/ -- On National Black HIV/AIDS Awareness Day, Thursday, February 7, AIDS Project Los Angeles will join concerned communities and AIDS advocates across the nation in calling attention to the HIV/AIDS state of emergency in the black community. AIDS is the leading killer of African-American
VIENNA, Va., Feb. 4 /PRNewswire-FirstCall/ -- The following letter is being sent by CEL-SCI CORPORATION (Amex: CVM) to its shareholders as part of the Annual Report: Dear Fellow Shareholders: This past year has provided CEL-SCI Corporation with remarkable new clinical data that could help us become uniquely positioned
BERNE, Switzerland , and NEW YORK, Feb. 4 /PRNewswire/ -- Swiss vaccine manufacturer Berna Biotech Ltd. has joined a cross-national team to test a new vaccine to prevent HIV infection and AIDS designed specifically for use in developing countries. Berna will produce doses of the vaccine for human trials starting this y
NEW YORK, Feb. 2 /PRNewswire/ -- The member companies of the World Economic Forum s Global Health Initiative (GHI) today joined with global health leaders and issued a call to the business leaders of the world to increase their efforts in the fight against HIV/AIDS, TB and malaria. Business leaders Raymond Gilmartin, C
NEW YORK, Feb. 2 /PRNewswire/ -- Addressing leaders at the World Economic Forum (WEF) in his capacity as co-founder of the Bill & Melinda Gates Foundation, Bill Gates, joined by pop star Bono of U2, today called on government, industry and not-for-profit organizations to substantially increase and sustain developme
RIXENSART, Belgium , Jan. 31 /PRNewswire-FirstCall/ -- Today, GlaxoSmithKline Biologicals (GSK Biologicals) announces the start of the first trial in humans of its recombinant, adjuvanted candidate HIV vaccine -- NefTat and gp 120 formulated with the proprietary adjuvant AS02. The main objectives are to see if the can
WILMINGTON, N.C., Jan. 30 /PRNewswire-FirstCall/ -- PPD Discovery, the drug discovery technology subsidiary of PPD, Inc. (Nasdaq: PPDI), today announced that it has regained full research, development and licensing rights to its targets for therapeutic agents against Human Immunodeficiency Virus (HIV), following a deci
SAN DIEGO, Jan. 30 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN) today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office covering core technology for the identification and enhancement or elimination of epitopes (protein fragments) responsible for activating a class
TARRYTOWN, N.Y., Jan. 30 /PRNewswire-FirstCall/ -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the publication of two scientific articles that underscore the clinical utility of its investigational drug, methylnaltrexone (MNTX), in reversing a wide range of side effects caused by opioid pain therapy.
CAMBRIDGE, Mass. and JERUSALEM, Israel , Jan. 29 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. today announced that it has received approval from the South African Medicines Control Council for the initiation of a Phase II clinical trial of Keryx s investigational drug candidate KRX-101 (sulodexide) for the
SAN DIEGO, Jan. 29 /PRNewswire-FirstCall/ -- Epimmune Inc. today provided an update on the status of its initial HIV vaccine candidate including clinical trial plans. The Company stated that, as additional time is necessary to complete all of the animal safety studies that were contemplated in its pre-IND discussions w
SACRAMENTO, Calif., Jan. 28 /PRNewswire/ -- Africamix, a California-based nonprofit organization announced today that UNICEF Africa will be a primary beneficiary of its traveling arts and music festival organized to help combat child abuse and neglect. The volunteer-organized and oriented festival is scheduled to visit
NEW HAVEN, Conn., Jan. 28 /PRNewswire/ -- Achillion Pharmaceuticals, a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative anti-infective agents, today announced that it has closed a $41 million private round of financing, placing its preferred stock to a sele
LOS ANGELES, Jan. 25 /PRNewswire/ -- AIDS Project Los Angeles (APLA) reacted with concern about the anticipated appointment of former Representative Tom Coburn (R-Oklahoma) as co-chair of the President s Advisory Council on HIV/AIDS (PACHA). In November, President Bush appointed Patricia Funderburk Ware, another conser
SANTA MONICA, Calif., Jan. 24 /PRNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation announced the election of former FDA Commissioner David A. Kessler, M.D. to chair its Board of Directors today. Philip A. Pizzo, M.D., another nationally renowned pediatrician, has been named vice chairman. Trained as a ped
ATLANTA, Jan. 24 /PRNewswire-FirstCall/ -- CytRx Corporation (Nasdaq: CYTR) today announced that scientists from Merck & Co. , Inc. published results in the science journal Nature on their vaccine research program against HIV which utilized CRL-1005, a component of CytRx s TranzFect technology. In November 2000 Me
YORK, Pa., Jan. 24 /PRNewswire/ -- Caring Together is a new partnership among WellSpan Health, York Health Corporation, and OPEN (Ordinary People Extraordinary Needs). It provides a coordinated system of care for patients living with HIV and AIDS. John McConville, M.D., chairman, Department of Medicine, York Hospital,
WASHINGTON, Jan. 23 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced a grant of $600,000 over three years to the AIDS Vaccine Advocacy Coalition (AVAC). Founded in 1995, AVAC is a consumer-based advocacy organization working to speed development and delivery of AIDS vaccines to populations throug
LOS ANGELES, Jan. 22 /PRNewswire/ -- AIDS Project Los Angeles (APLA) and Pallotta Teamworks, originator and producer of California AIDSRide, today announced the lead beneficiaries of California AIDSRide 9. For the first time ever, California AIDSRide will benefit HIV/AIDS charities throughout California, opening up fun
WASHINGTON, Jan. 18 /PRNewswire/ -- In its continuing efforts to provide care to more than 80,000 veterans infected with hepatitis C, the Department of Veterans Affairs (VA) on Jan. 1, 2002, funded four new centers to evaluate and improve hepatitis C screening, testing, clinical care and education. These new centers wi
SAN DIEGO, Jan. 18 /PRNewswire-FirstCall/ -- Research results published in the scientific journal Nature describe the use of the Vical Incorporated (Nasdaq: VICL) naked DNA technology in the ongoing efforts to develop a vaccine to combat human immunodeficiency virus (HIV). The report in Nature described studies conduct
BALTIMORE, Jan. 18 /PRNewswire/ -- When Africa s equivalent of the Super Bowl kicks off this weekend, millions of young male soccer fans will be urged also to Play for Life and prevent HIV/AIDS infection. The Play for Life/Jouer pour La Vie campaign will be officially launched Saturday as the 23rd African Cup of Nation
DURHAM, N.C., Jan. 17, 2002 /PRNewswire-FirstCall/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) today provided updated information on the development of two of its HIV compounds, Coviracil and Coactinon. Following recent discussions with the FDA , Triangle now plans to submit a New Drug Application (NDA) early this
GAITHERSBURG, Md., Jan. 17 /PRNewswire/ -- Panacos Pharmaceuticals, Inc. today announced the appointment of David E. Martin, PharmD to the position of Vice President, Drug Development. Dr. Martin joins Panacos from Bristol-Myers Squibb (formerly Dupont Pharmaceuticals) where he worked from 1999, most recently as Direct
NEW YORK, Jan. 15 /PRNewswire/ -- More than 60 religious leaders from Africa, the Caribbean and the United States are attending the first African Diaspora HIV/AIDS Summit this week to discuss the impact of AIDS throughout the African Diaspora. This historical conference will convene the religious heads to examine the c
PASADENA, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Judy McGrath, President, MTV Group and Chairman, Interactive Music, MTV: Music Television and Bill Roedy, President, MTV Networks International, announced today that U.S. Secretary of State Colin Powell will participate in an international Global Forum with young adul
WASHINGTON, Jan. 11 /PRNewswire/ -- The U.S. Government recently issued a report that implements the Support for Overseas Cooperative Development Act. This report sets a new agenda for overseas cooperative development. The implementation plan is the most significant cooperative development event in forty years, said T
LOS ANGELES, Jan. 10 /PRNewswire/ -- AIDS Project Los Angeles (APLA) applauds Governor Gray Davis commitment to HIV/AIDS programs reflected in his budget proposal for fiscal year (FY) 2002 - 2003. Considering the tough economic situation the State of California faces, this budget offers much hope for people living with
WASHINGTON, Jan. 10 /PRNewswire/ -- The Community Programs for Clinical Research on AIDS (CPCRA) announces the start of the SMART Study (Strategies for Management of Anti-Retroviral Therapy). The study is being carried out by 16 units in the CPCRA, 5 other sites in the United States , and sites in
GAITHERSBURG, Md., Jan. 10 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that it has signed a Letter Contract authorizing it to commence work for the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) using GenVec s propr
VIENNA, Va., Jan. 9 /PRNewswire/ -- CEL-SCI CORPORATION (Amex: CVM) announces that a presentation on CEL-SCI s immunotherapy drug, Multikine, by scientists from The Institute of Human Virology (IHV) at the University of Maryland, Baltimore, was accepted at the Society of Gynecologic Oncologists (SGO) Annual Meeting in
GAITHERSBURG, Md., Jan. 9 /PRNewswire/ -- Panacos Pharmaceuticals, Inc. today announced the appointment of Sandra Nusinoff Lehrman, M.D. to its Board of Directors. Dr. Lehrman has more than 18 years experience in senior executive management within the pharmaceutical and biotechnology industries, most recently as Presid
COSTA MESA, Calif., Jan. 7 /PRNewswire/ -- ICN Pharmaceuticals, Inc. (NYSE: ICN) announced today that an Investigational New Drug Application (IND) has been submitted to the U.S. Food and Drug Administration ( FDA ) to begin clinical testing of ICN s nucleoside analog viramidine for the combination treatment of chronic
INDIANAPOLIS, Ind. and CAMBRIDGE, Mass., Jan. 7 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that they have selected LY570310 (VX-950), a novel small molecule protease inhibitor for the potential treatment of hepatitis C virus (HCV) infection,
VIENNA, Va., Jan. 7 /PRNewswire/ -- Maximilian de Clara, President of CEL-SCI Corporation (Amex: CVM), and Geert Kersten, Chief Executive Officer of CEL-SCI Corporation, sent the following letter to CEL-SCI s shareholders: Recently, we have experienced a remarkable new discovery with our immunotherapy drug, Multikine(T
BRISBANE, Calif., Jan. 7 /PRNewswire/ -- VaxGen , Inc. (Nasdaq: VXGN) announced today that the journal Vaccine has published findings suggesting that the company s HIV/AIDS vaccine, AIDSVAX B/B, induces antibodies to the five most common HIV subtypes. The article, by Sandra A. Lee et al. at VaxGen (Vaccine 20 (2002) 53
LOS ANGELES, Jan. 6 /PRNewswire/ -- AIDS Project Los Angeles (APLA) is pleased with the definition of an HIV Specialist proposed by Governor Gray Davis and the California Department of Managed Health Care today. On October 14, 2001, Governor Gray Davis directed the California Department of Managed Health Care to fully
SAN DIEGO, CA, Jan. 4 /PRNewswire/ - Stressgen Biotechnologies Corporation (TSE:SSB) announced today that the U.S. Patent and Trademark Office had issued Patent Number 6,335,183, for which the Company has an exclusive worldwide license from the Whitehead Institute for Biomedical Research. The patent grants exclusivity
SANTA MONICA, Calif., Jan. 3 /PRNewswire/ -- Mark Burnett, the executive producer of Survivor: Africa, has partnered with the Elizabeth Glaser Pediatric AIDS Foundation to highlight the global HIV/AIDS epidemic and the work the Foundation is doing to prevent mother-to-child transmission (MTCT) of HIV. This ongoing comm
HAYWARD, Calif., Jan. 3 /PRNewswire/ -- Lynx Therapeutics, Inc. (Nasdaq: LYNX) announced today an AIDS research collaboration with Dana-Farber Cancer Institute (DFCI). The goal of this research collaboration with Wayne A. Marasco, M.D., Ph.D., a leading AIDS researcher, is to identify cellular targets that could be use
This information is designed to support, not replace, the relationship that exists between you and your doctor.